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Abstract
This thesis shows a novel contribution to computational biology alongside with developed ma-
chine learning methods. It shows how the graphical representation of KEGG pathways can be
refined using machine learning of graphical models. The focus mainly is on a set of graphical
models called Bayesian networks. Throughout this thesis , different ways of learning Bayesian
networks are discussed. The work is based on Affymetrix gene expression microarray profiles
and penalised Gaussian linear models. Penalisation in linear models includes choosing the most
important parents and estimating the associated coefficients simultaneously using L1-regression.
The sparse dataset that is generated from Affymetrix microarray technology is the key point in
this thesis when learning Bayesian networks. Thus, the work in this thesis can be viewed as de-
veloping robust methods to avoid overfitting that usually associated with gene expression datasets
and contributing to invoke more details about a well known discrepancy in KEGG pathways. So,
the problem we have is to learn from a large number of candidates, small samples,(p n), and
for such problem the goal is to apply model selection methods that hopefully achieve an accu-
rate prediction , interpretable models, and stable models. The prediction and the most powerful
predictors can be improved by using methods that trade-off between bias and variance. Also, pro-
viding which predictors are meaningful rather than using all predictors will provide interpretable
models, and finally by choosing the most important predictors, a small change in the data will
not result in large changes in the subset of predictors which consequently gives the stability to
the models that are learnt.
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CHAPTER 1
Introduction and Motivation
.This chapter gives an overview of the field of Artificial Intelligence in microarray analysis (Sec-
tion 1.1). It discusses the validity of machine learning when sparse datasets are presented, es-
pecially from microarray technologies. Section 1.2 points out one of the main difficulties that
exists when dealing with microarray datasets, the dimensionality of gene expression datasets and
the overfitting problem that is associated with this. Section 1.3 gives a detailed account of the
motivation and the research hypothesis behind the work in this thesis, which is based on a well
known graphical representation for molecular interactions, the Kyoto Encyclopedia of Genes and
Genomes (KEGG), and how machine learning of graphical models can be used to invoke more
detailed knowledge about molecular interactions in KEGG. Finally, a compact view of the thesis
chapters is given in Section 1.4.
1.1 Introduction
Recently, Artificial Intelligence (AI) has become an interdisciplinary field with medicine and
biology. The huge amount of data that is available from modern technologies in medicine and bi-
ology is the key to AI success in developing medical treatments and tracking how cellular systems
work inside the body. One of the prominent AI branches that can be used to develop therapies and
discover knowledge about genomic interactions is the discipline of machine learning. Machine
learning has been used intensively as a tool to reveal and discover complex molecular biological
interactions that could not have been found manually or might have taken a long time to be dis-
covered in the biological laboratory.
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One of the most successful technologies, which transformed 20th century genetics into 21st cen-
tury genomics, is microarray technology. The microarray has become one of the main tools in
wet-labs that conduct molecular experiments. Microarrays are used to measure the expression
level of thousands of genes simultaneously. In the face of such vast amounts of gene expression
data, powerful methods are needed to extract useful knowledge and make sense of this data for
further analysis. In the past, no more than a few genes could be studied at a time. However,
the human body has more than 20,000 genes; to study each gene one at a time would take an
extremely long time, but with the rapid development of high throughput technologies, such as
the microarray, it has become possible to look at all the cell genes in one go. The result of us-
ing microarrays is rather complex data, which a biologist cannot analyse without using powerful
tools to help pre-process, reveal and visualise important findings from such data. Therefore, ma-
chine learning and statistical methods are found to provide useful solutions for the genomic and
proteomic era.
One of the hot topics within both the biology and medicine communities is how to treat can-
cer. The treatment of cancer has brought different disciplines together to contribute to improving
human life. At the present time, cancer is stopped or treated by using chemotherapy, which is
sometimes effective to stop the spread of cancer, but also results in side-effects to the healthy
cells inside the body. Therefore, efforts are being made to find advanced therapies that can be
used to target the cancerous cells alone, rather than the whole body, which will result in prevent-
ing an adverse effect to other cells in the body. The study of cancer using clinical factors (such
as age, weight, etc.) has not been found enough on its own to diagnose and treat cancer. There-
fore, DNA-microarray technology is being used to look at the low level causes of cancer. As
an example, a healthy cell and a cancer cell can be compared using DNA-microarrays to look at
the differences and the similarities between these two cells and make a decision on which genes
should be targeted and diagnosed as causes of cancer. The result of microarray experiments,
which are gene expression profiles, is generally massive data, which fits perfectly to machine
learning algorithms. The ability of machine learning to search and find different hidden informa-
tion from gene expression datasets has already been proven. One example is finding interactions
at a low level between thousands of genes, resultant from microarray experiments.
1.2 On the Dimensionality of Gene Expression Microarrays
One of the main challenges in dealing with microarray data is the dimensionality of the data.
Gene expression data usually has thousands of genes as variables and they are measured in only
a few samples. Therefore, getting reliable information from such large dimensional datasets
is hard. Algorithms that can robustly deal with a big feature space are required. Thus, one
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of the main motivations in this thesis is to develop a machine learning algorithm that not only
works in high dimensional space, but also with small sample sizes. One problem that is often
encountered when dealing with microarray gene expression data is overfitting, which occurs
when thousands of genes and small sample sizes are used for learning. This problem will be
investigated throughout the thesis. We will show how the difficulty of dimensionality can be
reduced using natural prior knowledge from molecular biology interaction resources such as
KEGG pathways (Kanehisa & Goto 2000; Kanehisa et al. 2010).
1.3 Motivation
In this section, a discussion of the state-of-the-art in the research hypothesis area will be given
which covers the discussion of a known discrepancy in the KEGG pathways. This section will
also discuss the origin of the gene families represented in KEGG pathways and how machine
learning of graphical models can increase the biological complexity in the KEGG signalling
pathways by adding extra information about how gene families interact with one other. Finally,
the formalisation of the proposed method will be given, as well as the evaluation used in this
thesis.
1.3.1 KEGG (Kyoto Encyclopedia of Genes and Genomes)
The amount of genome sequence data, which has increased in the last few decades, is at the
core of understanding life as a molecular system. It also helps greatly in developing medical
and pharmaceutical applications. The Kyoto Encyclopaedia of Genes and Genomes (KEGG), a
knowledge-based method developed in 1995, aids our understanding of the high-order systematic
behaviour of cells and organisms, based on genomic and molecular systems (Kanehisa & Goto
2000; Kanehisa et al. 2010).
KEGG is a graphical representation that is used for analysing:
• Gene functions (KEGG GENES): a group of gene categories for all the completely se-
quenced genomes and some partial genomes, with up-to-date annotations of gene func-
tions.
• KEGG LIGAND: consisting of chemical building blocks for endogenous and exogenous
substances.
• KEGG PATHWAYS: represent molecular relationships and reactions networks. These net-
works can be grouped as follows:
1. The set of chemical reactions (metabolism) that happen in living organisms. These
processes allow organisms to grow, reproduce and respond to their environment.
2. Genetic information processing, such as DNA replication.
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3. Environmental information processing, such as signalling molecules and interactions.
4. Cellular processes, such as the growth and death of cells.
5. Human diseases, such as cancer. Figure 1.1 shows an example of how genes react
with one another in the context of the cancer signalling pathway shown in KEGG.
The interpretation of notations used in Figure 1.1 is shown in Figure 1.2. As can be
seen from Figure 1.2, KEGG pathways mostly represent protein-protein interactions,
but some are at the gene expression level.
• KEGG BRITE: a collection of hierarchical classifications showing knowledge of various
aspects of biological systems. In comparison with KEGG PATHWAY, KEGG BRITE
provides many different types of relationships not shown in KEGG PATHWAYS, so that
KEGG BRITE can be viewed as a global picture of KEGG PATHWAYS. Figure 1.3 shows
a hierarchical diagram of the different kinds of representations available in KEGG.
 
Figure 1.1: Part of cancer pathways as shown in KEGG [Kanehisa Laboratories, 2009].
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Figure 1.2: Notations in KEGG pathways diagrams[Kanehisa Laboratories, 2009].
Traditionally, biologists have attempted to understand cellular processes using a reductionist
approach, which looks at the effects of manipulating a small number of genes in a living organ-
ism. KEGG pathways aid as a means of visualising the interactions between genes, mostly at the
protein level, in the form of cell signalling pathways. The PATHWAY component in the KEGG
database provides generic representations of cell signalling pathways. For example, in the WNT
signalling pathway, depicted in Figure 1.4, KEGG shows that WNT proteins interact with Friz-
zled proteins (FZD). There are 19 WNT proteins (WNT3, WNT5, WNT7,...) in the WNT family
and 10 FZD proteins (FZD1, FZD2, FZD7,...) in the Frizzled family listed in the KEGG database.
A gene/protein family in KEGG PATHWAYS is a group of genes/proteins that are grouped to-
gether. The groupings are based on different criteria. One reason is gene duplication, a pro-
cess by which a chromosome or a segment of DNA is duplicated, resulting in an additional
copy of a gene, which evolves through mutations to create new different functional genes that
share important characteristics. For example, similar sequences of DNA building blocks (nu-
cleotides) (Zhang 2003). A well-known mechanism after gene duplication is neofunctionaliza-
tion in which one of the duplicates keeps the inherited functions, while the other continues to
evolve for new functions (Tirosh & Barkai 2007). Another reason for grouping genes/proteins
together in one family is that the proteins produced from genes in the same family work together
in the same processes, which are needed for living organisms.
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Figure 1.3: A hierarchical diagram illustrating KEGG components
1.3.2 Research hypothesis
KEGG pathways provide a useful level of abstraction for understanding the overall structure of
cell signalling pathways. Each signalling pathway gives an overview of how gene families react
with each other at the protein level or at the gene expression level. For example, the interaction
between the WNT family and the Frizzled family is at the protein level, as shown in Figures 1.2
and 1.4. However, each gene/protein family can have several genes, for reasons mentioned pre-
viously. For example, in the WNT-signalling pathway, shown in Figure 1.4, the WNT family that
appears in the upper left-hand corner has 19 proteins, including WNT5a, WNT6 and WNT10.
Moreover, some gene families exist in all four pathways, which provides an opportunity in the
future to link the pathways together to provide a better understanding of how a disease, for exam-
ple cancer, develops. As a result, treatment could be limited to genes rather than the whole body.
This means that if we can find the genes that are responsible for inducing and stimulating cancer
to grow, we can target them, instead of applying chemotherapy to the whole body. In addition,
the better we understand the cellular reaction, the better we understand the disease.
Furthermore, there is an increasing availability of gene expression data on the whole genome
level, in the form of DNA-microarray experiments, coupled to mathematical and computational
techniques that can take account of the relationships between large numbers of genes. Using
these techniques will potentially enhance our understanding of the higher order molecular sys-
tems that regulate cellular growth.
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it is well known that a gene produces a protein via a transcriptional step called Ribonucleic
acid(RNA). It has been studied extensively in (Webb & Westhead 2009) that it is relevant to use
gene co-expression to indicate potential functional linkage at the protein level. Moreover, the
level of transcriptional regulation of protein complexes has been examined in (Jansen et al. 2002)
and it was found that the presence of certain interactions between protein complexes is directly
associated with the coherency of their expressions at the transcriptional levels. Therefore, the in-
teraction of genes at the gene expression level can indirectly enhance our understanding of how
protein-protein interaction might occur. Also, since protein-protein interactions in the same path-
way are most often co-expressed, then finding a more detailed picture of how the genes interact
with each other at the gene-expression level will possibly lead to understanding the interaction
of these genes at the protein level. Hence, the work in this thesis will be as an indirected learn-
ing methods,via gene expression signatures, to understand most of the unknown protein-protein
interaction between families represented in the KEGG PATHWAYS in addition to understand
the detailed interaction between gene families that are already represented in KEGG, at the gene
expression level.
This thesis looks at the prostate cancer disease networks that are part of human disease, in the
KEGG PATHWAYS, (Figure 1.3). The focus is on research by (Birnie et al. 2008), in which
microarrays were used to compare gene expression patterns between prostate cancer samples
and benign controls to identify genes that have significantly different gene expression signatures
in their stem cells from those in committed basal cells. Samples from cancer and non-cancer
were used in this study. The gene expression signatures described in (Birnie et al. 2008) were
found to be enriched for genes from four main KEGG PATHWAYS, JAK-STAT signalling, WNT
signalling(Figure 1.4), the cell-extracellular matrix interaction pathway and the focal adhesion
signalling pathway. It is increasingly apparent that studying small numbers of genes in isolation
does not provide sufficient understanding of the higher order systemic processes that regulate
cell growth. Thus, we are becoming interested in finding methods that provide a picture of how
genes inside gene families might interact/co-express with each other and also how they interact
with those around them, based on transcriptional gene expressions. In general, KEGG pathways
only show a higher level of interaction between gene families. More precisely there is no exist-
ing mechanism to access the specific connections between gene families that underlie the generic
connections represented in the KEGG signalling diagrams. For example, the WNT signalling
pathway in Figure 1.4 shows that the WNT family/component directly interacts with Frizzled,
but it does not show which member of the WNT family interacts with which in the Frizzled fam-
ily or how genes inside the WNT family interact with each other.
Discovering the low level interaction between gene families will provide new insights into genome
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evolution, because for example neofunctionalization resultant from gene duplication is believed
to involve novel functionality for the new duplicated genes (Tirosh & Barkai 2007).
Thus, the main contribution of this thesis is to extend and refine the representation of the four
KEGG PATHWAYS mentioned in (Birnie et al. 2008), to include more details and additional
knowledge about the molecular representations and reaction networks. This is done by using
machine learning of graphical models on gene expression data. Hence, this thesis contributes to
computational biology, along with developing machine learning methods. The focus is mainly
on a set of graphical models called Bayesian networks, and throughout this thesis, we present
and discuss different ways of learning Bayesian networks. Since microarray gene expression
profiles are used when learning graphical models, an overfitting problem is a concern. Gene
expression datasets often have more genes than samples (p >> n) which makes it difficult to
learn meaningful cellular graphs for KEGG PATHWAYS. Therefore, we show extensively how it
is possible to overcome the overfitting problem when sparse datasets are used. For this purpose,
penalised Gaussian linear models are used. Penalisation in linear models includes choosing
the most important parents and estimating the associated coefficients simultaneously using L1-
regression. Thus, another view of the contribution of this thesis is the development of robust
methods to avoid the overfitting which is usually associated with gene expression datasets. Fi-
nally we evaluated the generated models based on prediction accuracy using leave-one-out-cross
validation(LOOCV).
1.4 Thesis Structure
This section gives a synopsis of all chapters covered in the thesis.
• Chapter 1: gives an introduction to the field of interest. It shows the use of machine
learning in microarray data analysis, along with the potential problems arising when using
small sample gene expression datasets. The last section focuses on the motivation behind
this thesis and a detailed discussion of the discrepancy in KEGG pathway representations
is covered.
• Chapter 2: shows background materials for techniques related to the problem of inter-
est. It presents a general discussion of different machine learning algorithms that are used
in microarray data analysis. It also considers how machine learning of graphical models
is used to infer cellular systems, and different sets of graphical models are discussed. It
then shows how machine learning is used to learn a well known set of graphical models,
Bayesian networks, and is concerned with learning the structure of Bayesian networks and
parameter estimation. This chapter also shows some work related to supervised and unsu-
pervised learning algorithms in cancer and also for graphical models of cellular systems.
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Figure 1.4: Wnt signalling Pathway [Kanehisa Laboratories, 2009]
• Chapter 3: has a broad discussion of the two types of cancer that are known to be the
most prone to metastasis (spreading), breast cancer and prostate cancer. It gives also a
detailed discussion about cell communication and Wnt-signalling pathway. At the end of
the chapter, we stress how genomic diagnosis is more robust than using clinical factors
such as age, gender, etc. in diagnosing cancer.
• Chapter 4: goes into detail about microarray technology. It shows different types of
microarray technologies. It also gives a detailed discussion of how gene expression profiles
are normalised using statistical methods. Finally, it shows how the gene expression datasets
that are used in this thesis are normalised.
• Chapter 5: is an experimental chapter in which the existing tools for learning Bayesian
networks are discussed. It highlights the advantages and disadvantages of using some
existing tools and introduces the new direction of how we will learn Bayesian(causal)
networks from gene expression datasets, which will lead to a more detailed representation
of four KEGG pathways.
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• Chapter 6: is about the main contribution of this thesis. It shows that the assumption
of multivariate normal distribution can be used to learn linear Gaussian models. It also
shows how co-expression networks can be learned by pair-wise correlation. This chapter
highlights the drawback that is encountered when co-expression networks are inferred. It
discusses how AIC and BIC scoring functions are used to learn models with less overfitting
from small sample sizes. It then introduces more severe methods against overfitting, which
were developed and could successfully learn meaningful causal networks from sparse gene
expression datasets.
• Chapter 7: gives a summary of all chapters included in the thesis. It points out the lim-
itations of the current work and looks at future work that is related to the context of this
thesis.
CHAPTER 2
Background
This chapter covers the background of the field of machine learning , graphical models, and their
applications to inferring cellular networks, including reviewing the literature. Section 2.1 gives
an introduction to Artificial Intelligence in medicine and biology in the context of cancer and
therapy development and the potential solutions machine learning might offer. Different machine
learning algorithms are discussed in Section 2.2, which discusses supervised learning algorithms
and their applications for class discovery in gene expression datasets, as well as unsupervised
learning algorithms with their applications in gene expression datasets from microarrays. In Sec-
tion 2.3, graphical models in general are discussed. This includes the graphical representation
for each set of graphical models and the dependency properties encoded in each set of graphical
representations. Section 2.4 details how to learn a Bayesian network, in addition to the problems
usually encountered when learning from datasets. Section 2.4.2 explains how to estimate the pa-
rameters present after the graph is learned from the data. In Section 2.4.3, inference in Bayesian
networks is discussed, including exact inference and approximate inference. In Section 2.5, a
broad survey of machine learning in cancer diagnosis and inferring cellular networks is shown.
2.1 Introduction
From the earliest beginnings of the modern computer, scientists hoped to create an electronic
brain with all the modern technological requirements. Scientists and doctors were captivated by
the potential such a technology might have in medicine; using the ability of intelligent systems,
such as machine learning, to store and process vast amounts of knowledge. The ambition was
that it would become a doctor in a box to assist and help clinicians and biologists with tasks
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like diagnosis and genomic analysis (Coiera 2003). Such motivations made it possible to create
a small community of computer scientists and health-care professionals who initiated a research
programme for a new discipline called Artificial Intelligence in medicine (AIM). An early defini-
tion was: Medical Artificial Intelligence is primarily concerned with construction of AI programs
that perform diagnosis and make therapy recommendations (Fentiman 1998). Since then, Arti-
ficial Intelligence in medicine and biology has become increasingly popular, as scientists realise
the complexity of making certain decisions to treat particular diseases. Furthermore, the use of
machine learning and data mining as tools in medical diagnosis and biology labs has become im-
portant, since the advantages of genomic technology, such as the Affymetrix microarray became
known. One practical use of machine learning is to reveal knowledge from vast genomic data
from microarray platforms.
Cancer is a critical disease, leading to death if not treated in its early stages. The disease is
very common and the second highest cause of death. In this chapter a broad survey of how ma-
chine learning is used in bioinformatics in the context of cancer will be given. Related work
in different machine learning algorithms concerned with inferring cellular networks will also be
covered.
2.2 Machine Learning for Microarray Analysis
One of the main uses of microarray experiments is to find and infer meaningful relationships
between genes. In this section, we will look closely at how machine learning can offer useful
methods for this purpose.
2.2.1 Supervised learning
In supervised learning algorithms, the data that is used has known classes and so the result is a
classifier that can later be used in predicting the classes for an unknown sample. Decision trees,
neural networks, naive Bayes, and support vector machines (SVM) are well known supervised
learning algorithms used in different applications.
2.2.1.1 Class discovery and prediction
In class discovery and prediction in respect of microarray data analysis, the aim is to predict
the class for a new sample. For example, it is possible to find out whether a gene based on its
transcriptional expression belongs to a malignant cell or a benign cell based on the training gene
expression that is used to train a classifier or a predictive model. In this section will look at
SVMs (Vapnik 1998), which are one of the main supervised learning algorithms used in class
discovery and prediction for microarray gene expression data, and often used in gene expression
data analysis.
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2.2.1.2 Support vector machines (SVMs)
A support vector machine (SVM) is a supervised learning algorithm that uses points to train a
classifier which can then be used to predict the class of unknown future samples. In SVM, the
classes of the training samples are determined by constructing a separable hyperplane between
training data points, which separates the data points into two classes. Thus, it is a binary classi-
fication method which aims to find the optimal hyperplane in the feature space that can separate
the data points into two classes. The advantage of SVMs is that they can work with large di-
mensional data, such as gene expression datasets, by mapping to a higher dimensional feature
space, in which a separable hyperplane can be constructed. The mapping is made using a kernel
function that has a mapping (Φ) from input space to feature space and that the aim to find the
optimal separable hyperplane. Figure 2.1 shows how the training data is mapped to a higher
dimensional space. A hyperplane is then fitted to separate the data points into two classes, in a
way that minimises the prediction error for a new, unknown class of future samples.
Figure 2.1: A kernel function is used to project the input data to a higher dimensional space
where the hyperplane is constructed (Newton 2001).
2.2.2 Unsupervised learning
In contrast to supervised learning algorithms, unsupervised learning algorithms use data without
prior knowledge of the classes and try to predict the classes through learning. Self organising
maps, Bayesian networks and clustering algorithms are the ones of the main unsupervised learn-
ing algorithms used in gene expression analysis. In this section, we present a discussion about
clustering, which is one of the main unsupervised learning algorithms used in microarray data
analysis.
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2.2.2.1 Clustering
Clustering algorithms are used in microarray data analysis to find the groups of genes that have
similarity in function. A typical example of this can be seen when different microarray experi-
ments are conducted across different conditions and a clustering algorithm is used to group the
genes with similar gene expressions over the experiments. A variety of clustering techniques
have been applied to microarray data and here we will describe two of the most widely used
techniques, partitioning clustering algorithms and hierarchical clustering algorithms.
Partitioning algorithms: in partitioning algorithms, a dataset is partitioned into K clusters,
based on the similarity between data points in the dataset. The similarity is measured using a
distance measure such as Euclidean distance (2.1).
d(i, j) =
√
(xi1 − xj1)2 + (xi2 − xj2)2 + ...+ (xip − xjp)2 (2.1)
Some properties of Euclidean distance and any metric in general are:
• d(i,j)≥0, where i,j are two points from the dataset.
• d(i,i)=0
• d(i,j)=d(j,i)
• d(i,j)≤ d(i,k) + d(k,j)
Hierarchical clustering: the idea of hierarchal clustering is to form a tree in which the root
takes all possible clusters and the leaves form every single data point each in its own cluster, in
between there are different layers of clustering, (Figure 2.2). The nodes in the tree can be viewed
as different stages of clustering. The uppermost node (the root) contains all the data points in one
cluster. Then, the nodes in the second layer separate the data points to different clusters based
on the similarity between these data points. The next layer spearates the clusters more until each
data point has its own cluster which forms the leaves of the tree. In contrast to partitioning
clustering algorithms, where data is partitioned into a particular cluster in one step, the data in
hierarchical clustering algorithms is partitioned in a series of steps.
There are two types of hierarchal clustering: agglomerative methods and divisive methods.
There are three kinds of agglomerative methods: single linkage, complete linkage and average
linkage. Single linkage clustering, also called nearest neighbour technique (NN), is one of the
simplest agglomerative hierarchal clustering algorithms. The distance between each cluster in
the single linkage method is defined as the distance between the closest points in two clusters,
(Figure 2.3). Complete linkage clustering is also known as the farthest neighbour clustering
method. The distance in complete linkage clustering is defined as the farthest distance between
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Figure 2.2: Hierarchical clustering (Newton 2001).
two points in two clusters, (Figure 2.4). The distance in average linkage clustering is the average
distance between all points in two clusters, (Figure 2.5).
Figure 2.3: Single linkage clustering.
2.2.2.2 Inferring cellular networks
Clustering algorithms provide a technique for discovering genes that are co-expressed. However,
as well as finding the similarity in expression between genes, it is also possible to infer the
transcriptional regulation between genes and construct a meaningful interaction network between
genes based on gene expression values. There are various graphical models techniques that
can be applied to inferring gene networks and discovering interactions between genes. In the
next section, we present a broad discussion of the most commonly applied graphical models in
microarray data.
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Figure 2.4: complete linkage clustering.
Figure 2.5: Average linkage clustering.
2.3 Overview of Graphical Models
In this section, an overview of different sets of graphical models, found to be the most commonly
used representation of variable relationships in a graph, will be given. The four sets of graphs
are : Markov networks (also called full conditional graphs), Bayesian networks, dependency
networks, and co-expression networks.
2.3.1 Markov networks
Markov networks, also called full conditional models (Figure 2.6), are undirected graphical mod-
els. For Markov networks, if the dataset is assumed to follow a normal distribution ∼ Np(µ,Σ)
with mean µ and covariance matrix Σ, and the covariance matrix Σ is invertible (Σ−1, called
a precision matrix), the value −kij/
√
kiikjj in the precision matrix is the partial correlation
coefficient between variables i and j. Therefore, it holds for i, j ∈ V with i 6= j that:
Xi ⊥ Xj |Xrest ⇔ kij = 0.
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Figure 2.6: an example of Markov Network.
Where Xrest is all variables except (Xi, Xj). Thus, Xi is conditionally independent from Xj
given all other variables (Xrest) which is equivalent to the element kij in Σ−1=0.0. This relation
is used to define Gaussian graphical models (GGMs) (Lauritzen 1996; Edwards 2000) and the
edges of GGMs are interpreted as non-zero partial correlations. The problem with GGMs is
that they only estimate the full conditional relationships accurately when the number of samples
exceeds the number of variables. However, the case in gene expression profiles, for example,
is that the number of genes (variables) exceeds the number of samples, p  n. Therefore, the
correlation matrix Σ does not have a full rank and hence cannot be inverted (Scha¨fer & Strimmer
2005a). Different studies suggest ways to estimate GGMs in a p  n situation; for example,
(Scha¨fer & Strimmer 2005b) suggests a linear shrinkage regularisation method.
2.3.2 Dependency networks
Markov networks, introduced in the previous section, are related to a set of graphical models
named dependency networks (DNs) (Heckerman et al. 2000). DNs (Figure 2.7) are constructed
by mapping a variable Y to its parents X.
The subset (Xx1,x2,..xi ) ∈ X that predict Y will be connected to Y by a directed edge. De-
pendency networks are used because of their computational advantage over Markov networks
and Bayesian networks when the graph is learnt from data. However, dependency networks are
not useful representations of causal relationships (Heckerman et al. 2000) and also do not define
a joint probability distribution due to the cyclicity in dependency graphs. Several different meth-
ods are proposed in the literature to learn the structure of dependency networks from data. One
example is to estimate the DNs using linear regression with penalised coefficients (Meinshausen
& Buhlmann 2006). Ridge regression and lasso are two examples of such penalised methods.
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Figure 2.7: an example of Dependency Network.
2.3.3 Bayesian networks
A Bayesian network (Figure 2.8) is a probabilistic model where the structure is a directed acyclic
graph (DAG) that encodes the dependences between a set of random variables. The individual
random variables are nodes of a DAG, which explains the dependency structure.
Each node in the graph is explained by a local probability distribution (LPD) and over all the
nodes the joint distribution p(x) can be defined as follows:
p(x) =
∏
v∈V
p(xv|xpa(v),θv ) (2.2)
Where θv denotes the parametrisation of the LPD and xpa(v) is the set of parent states. The
DAG structure implies an ordering of the variables. The parents of each node are those nodes
that make the child node independent of all non-descendant nodes in the graph representation.
The factorisation of the joint distribution in (2.2) is a property of Bayesian networks, which al-
lows us to decompose the graph into a set of families. Therefore, when it comes to learning a
Bayesian network from data, it is possible to decompose the structure learning for each family
individually if an ordering is given between variables. Thus, for each variable we seek the best
predictor parents separately and then join them to form a directed acyclic graph. For example,
to learn a Bayesian network from gene expression data, we can take each gene and search for
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Figure 2.8: An example of a Bayesian network
the best parents for it in a decomposed manner if a prior knowledge is given about the possible
causal parents for this gene, finally joining all the sub graphs for each family together to give a
full picture of a cellular graph. However, the interpretation of a Bayesian network when learning
a graph from gene expression data is always important.
Learning a causal acyclic network is similar to learning a Bayesian network. Causal networks can
be interpreted as Bayesian networks when the Causal Markov assumption holds. Thus, given the
values of a variable’s immediate causes, it is independent of its earlier causes. When the causal
Markov assumption holds, the causal network satisfies the Markov independencies of the corre-
sponding Bayesian network (Friedman et al. 2000). The interpretation of causality from Bayesian
networks has received a great deal of treatment in the literature (Heckerman et al. 1997; Pearl &
Verma 1991; Spirtes et al. 2000). Another well known method for inferring causality networks
is intervention, which uses some methods which force genes to be ’knocked out’. Another way
of making causal graphs but using observations only is by using causal prior knowledge to guide
the learning algorithm when learning the parents for each gene. This also implies that if causal
background knowledge is used to learn a Bayesian network, then it will also hold that the resul-
tant graph can be interpreted either as a causal or Bayesian network.
It is also worth knowing that Markov networks and Bayesian networks represent different sets
of independences between variables. For example if we have a Bayesian network such as:
A → B ← C, this graphical representation implies that A is independent from C, A ⊥ C.
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However, this sort of conditional independence relationship cannot be expressed using a Markov
network.
2.3.4 Co-expression networks
Co-expression networks are one of the simplest representations of variable relationships used in
gene co-expression relationships. The idea is based on the following: if two variables show sim-
ilar behaviour, for example, expression values in the gene expression profiles, they are supposed
to follow the same regime. Co-expression networks (also called relevance networks) are worked
out by computing a similarity score for each pair of variables. If the similarity is above a certain
threshold, the two variables are connected to each other in the graph, otherwise they remain un-
connected.
The similarity between two variables can be calculated in different ways. One example is cor-
relation coefficients (r) (2.3). Given that the data is drawn from a multivariate normal distri-
bution, zero correlation between two variables corresponds to statistical independence and an
unconnected edge in the graph between the two variables. Correlation networks can be eas-
ily interpreted and accurately estimated even in situations with large variables, small sample
size (Markowetz & Spang 2007). Measuring the correlation between two variables using (2.3)
will only concern the linear relationship of independence between any pair variables. Other
flexible similarity measures, like mutual information, can be used as a non-linear measure of in-
dependency (Butte et al. 2000). Co-expression measurements produce undirected graphs, unless
certain prior knowledge, such as the KEGG database, is used for directionality.
r =
n∑
i=1
(Yi − Y¯ )(Xi − X¯)√
n∑
i=1
(Xi − X¯)2
√
n∑
i=1
(Yi − Y¯ )2
(2.3)
2.4 Machine Learning of Graphical Models
The first part of this section discusses how a graph is learned and how the parameters for the
learned graph are estimated. Then, it dicusses the inference in machine learning of graphical
models. The second part covers related work for learning graphical models from gene expression
microarray data and briefly about the diagnosis of cancer using supervised learning algorithms.
2.4.1 Learning graphical models
To learn a graphical model, two parts have to be taken into account: firstly, learning the structure
of the graph, and secondly, learning the parameters for the graph. There are different ways to
learn the topology of a graph for a given problem. One way is from domain knowledge. In this
method, the variables that are needed in the domain problem have to be determined. The rela-
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tionships between these variables also have to be designated, and the last step is then to induce
the parameters for the constructed network. However, it is not always possible to construct a
graphical model from domain knowledge, for example, constructing a causal graph from observ-
ing the behaviour of genes in the lab is expensive. Another way to learn a graph is from data.
To do this, a structure for the graph is needed and also a complete dataset(it is possible to learn
from incomplete data but is harder)to estimate the parameters for the structure. However, most
real-world problems have unknown structures and sometimes suffer from incomplete datasets.
The following section shows how a Bayesian network is learned from data, assuming a complete
dataset, and then how the parameters are inferred for the learned structure.
2.4.1.1 Learning Bayesian networks from data
When data is used to learn Bayesian networks, firstly we need to learn the structure of the
Bayesian network if it is unknown. Secondly, we learn the parameters for this network, us-
ing conditional probability tables (CPTs). However, learning the structure of Bayesian network
is an NP-hard problem. To illustrate this, Table 2.1 shows how difficult it is to search all possible
Bayesian networks for different sets of variables, as the number of graphs grows exponentially
with the number of variables. Even with a small number of variables, there are many possi-
ble Bayesian networks, Directed Acyclic Graphs (DAGs), in the search space and searching all
DAGs to find the best graph that fits the data is difficult.
Table 2.1: The corresponding DAGs for each set of variables
Number of variables in DAG Number of possible DAGs
1 1
2 3
3 25
4 546
5 29281
6 3781503
7 1.138.779.265
8 78.370.2329.343
9 1.213.442.454.842.881
10 4.175.098.976.430.598.100
Chickering et al (Chickering et al. 2004; Chickering 1996) shows that finding the highest-
scoring Bayesian network is NP-hard, regardless of the size of the data, when a consistent scoring
criterion ,such as BDe score function, that favours a model with fewer model parameters is used.
Therefore, learning Bayesian networks from data is largely based on heuristics or moderately
greedy search algorithms. However, if a combination of data and domain knowledge is possible,
complete search algorithms can be used, as the prior knowledge will shrink the search space to
an admissible search , constrained by data and prior knowledge, such as that from KEGG, as we
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will show.
There are many algorithms designed for searching the most probable structure for a network
and in this section we will discuss some of them. In general, there are two main approaches for
learning Bayesian networks from data, search and score algorithms and constraint-based algo-
rithms. Search and score algorithms attempt to identify the networks that maximise/minimise a
score function, which expresses how well a network fits the data. The K2 algorithm and Genetic
algorithms are two greedy search examples of such methods of learning (Cooper & Herskovits
1991; Larranaga et al. 1996). Constraint-based algorithms start by assuming that all variables in
the network are dependent on each other. Then, an estimation is taken from the data of whether
certain conditional independencies between the variables exist (Spirtes et al. 2000). The PC
algorithm is an example of the constraint-based approach.
K2 algorithm: The K2 algorithm (Cooper & Herskovits 1991) assumes that an ordering of
the variables in the dataset exists. When it searches the possible parent nodes pis for a node xi it
considers only those parents that come before xi in the dataset. The best parents for each xi are
subject to maximising the following score function:
f(i, pii) = Π
qi
j=1
(ri − 1)!
(Nij + ri − 1)!Π
ri
k=1αijk! (2.4)
where:
pii is the set of parents of node xi.
qi = |φi|.
φi is the list of all possible instantiations of the parents of xi in dataset D.
ri = |Vi|.
Vi is the list of all possible values of the attribute xi.
αijk is the number of cases (i.e. instances) in D, in which the attribute xi is instantiated with its
kth value, and the parents of xi in pii are instantiated with the jth instantiation in φi.
Nij =
∑ri
k=1 α(ijk) . That is, the number of instances in the database in which the parents of xi
in pii are instantiated with the jth instantiation in φi.
K2 heuristically searches for the most probable Bayesian network from a given dataset of vari-
ables. This algorithm starts with a node without parents and then adds each parent that is likely
to increase the probability of a structure being the correct structure. The K2 algorithm adds new
parents, until adding a new parent does not increase the score function. (Ferrazzi et al. 2007)
used the K2 algorithm to learn dynamic Bayesian networks from gene expression data and pro-
vided a tool that we will discuss and use in the thesis.
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The PC algorithm Another approach to learning a Bayesian network is using constraint-
based algorithms. One example is the PC algorithm (Spirtes et al. 2000) which starts by con-
necting all variables to each other. In other words, it assumes that all variables are dependent on
each other and then verifies the conditional independencies for each pair, for all possible orders:
N=0: X1 is independent from X2, X1 ⊥ X2.
N=1: X1 is independent from X2, given X3, X1 ⊥ X2|X3.
N=2: X1 is independent from X2, given X3 and X4, X1 ⊥ X2|X3, X4.
N=3: ...
The PC algorithm follows the verification by using a statistical test. It starts with a given
undirected graph. The null hypothesis is then made (H0) that X1 is independent from X2, X1 ⊥
X2. After that a statistical test is used to show whether H0 is rejected, and X1 and X2 are
dependent (the alternative hypothesis H1). Chi-square (χ2) and the degree of freedom (df) are
used for testing the independencies in PC.
2.4.2 Parameter estimation
The second part after learning the structure of a graph, using for example Bayesian networks, is
to learn the parameters of such graphs. One example of a parameter estimation method is the
maximum likelihood estimator (MLE), a frequentist estimator, which is considered to be a non-
Bayesian estimator. The MLE estimator is used to obtain the conditional probability table (CPT)
for each node in the graph. In this section, an example will be given to show how the parame-
ters can be estimated from data after the graph has been learned. For a simple binary Bayesian
network structure (X −→ Y ) the parameterisation for this graph consists of the following pa-
rameters:
θx0 , θx1 specify the probability of two values of X.
θy0|x1 , θy1|x1 specify the probabilities of Y, given X= x1,(Y |X = x1).
θy0|x0 , θy1|x0 specify the probabilities of Y, given X= x0,(Y |X = x0).
Since the sample data has two variables, then each example can be given as < x[m], y[m] >,
where m is the sample size. As a result, the likelihood function is:
L(θ : D) = ΠmP (x[m], y[m] : θ) (2.5)
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For the simple Bayesian network here the equation can be written as:
L(θ : D) = ΠmP (x[m] : θ)P (y[m]|x[m] : θ) (2.6)
= ΠmP (x[m] : θ))(ΠmP (y[m]|x[m] : θ))
The first term from (2.6) can be calculated straight from the data since it does not depend on
any other variables. The second term in 2.6, however, will be decomposed further as follows:
Πm:x[m]=x0P (y[m]|x[m] : θY |x0),Πm:x[m]=x1P (y[m]|x[m] : θY |x1) (2.7)
where Y=y0, y1
Thus, to maximise, for example the parameter θY=y1 |x0 , we say that the maximum likelihood
for this parameter is:
θy1|x0 =
M [x0, y1]
M [x0, y1] +M [x0, y0]
=
M [x0, y1]
M [x0]
(2.8)
Where M [xi, yi] denotes how many times this example been encountered in the dataset.
In general, to learn the parameters for a Bayesian network with structure G and parameters
θs, given a dataset consist of samples D1, D2, ..., Dm the maximum likelihood function is given
as follows:
L(θ : D) = ΠmPG(D[m] : θ)
L(θ : D) = ΠmΠiP (xi[m]|pai[m] : θ)
L(θ : D) = ΠiΠmP (xi[m]|pai[m] : θ) (2.9)
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Another way of estimating the parameters for a learned graph is by using a Bayesian approach
that gives prior probability distribution over θs, before observing the data. Thus, the parameters
are considered as random variables and we use Bayes theorem (2.10) to update θs to get the
posterior probability distribution for each θ:
P (θ|d) = P (d|θ)P (θ)
P (d)
(2.10)
2.4.3 Inference
After learning the structure and estimating the parameters of a graph, it can be used to make
inferences. As an example , if we have a causal network that represents the relationship between
flu and high temperature as Flu → highTemp and each variable in this graph has two values,
either True or False, then we can assign conditional probability distribution (CPT) to this graph;
thus, we have a prior probability for Flu and CPT for highTemp. So, for a new patient, based on
their temperature, we can infer whether they have flu or not.
This kind of inference is called exact inference as it is simple to use Bayes theorem to find
the probability of having flu, given the patient’s temperature. The most common exact inference
methods are: variable elimination; clique tree propagation; and recursive conditioning. However,
in most cases doing exact inference is computationally complex and known to be an NP-hard
problem (Cooper 1990). Therefore, an approximate inference is used instead. The most common
approximate inference algorithms are: stochastic MCMC simulation; generalised belief propa-
gation; and variational methods.
2.5 Related work
The field of machine learning is not new in cancer research. Many algorithms have been pro-
posed in cancer detection and diagnosis in the last 20 years(Joseph A. Cruz 2006). Machine
learning algorithms are used in detecting and classifying tumours via X-ray and CRT images,
and in the classification of malignancies from proteomic and genomic data, using Affymetrix mi-
croarrays. The latest PubMed statistics show that more than 1,500 papers have been published on
the subject of machine learning and cancer. The majority of these papers are concerned with how
machine learning algorithms are used to identify, classify, detect or distinguish tumours and other
malignancies. A few papers are concerned with using machine learning to find the probability of
developing cancer before its occurrence (susceptibility). Nearly half of the papers that have been
published, are on predicting the likelihood of redeveloping cancer after removing it( recurrence).
About 43% of the papers have been about predicting life expectancy and tumour-drug sensitivity
after the diagnosis of the disease (Joseph A. Cruz 2006). Since breast cancer and prostate cancer
are the most frequent diseases to occur, machine learning algorithms have been applied exten-
sively to these diseases. Figure 2.9 shows that the strongest preference has been made for using
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machine learning in breast cancer and then in prostate cancer.
Artificial neural networks (ANN), decision trees (DT), graphical models and support vector
machines (SVMs) are the most commonly algorithms being used in cancer. ANN and DT for
instance, have been used to classify benign tumours from malignant tumours. Bayesian network
learning algorithms have attracted huge attention for constructing gene regulatory networks. Re-
search has also been conducted to compare three different algorithms, ANN, C4.5 and logistic
regression (Delen et al. 2005). In this study, the three algorithms were to predict the survivability
rates of breast cancer patients. The results indicate that the decision tree (C4.5) has the best pre-
dictor with 93.6% accuracy. SVMs have also been used for the diagnosis and prognosis of breast
cancer and (Zafiropoulos et al. 2006) shows that SVM algorithms have achieved high values of
accuracy (96.61%).
 
Figure 2.9: The percentage of machine learning applied in different types of cancer(Joseph
A. Cruz 2006).
Moreover, graphical models learning algorithms are being used in detecting and diagnos-
ing cancer from genomic datasets. Generally, using graphical models to learn different kinds of
networks from gene expression data are referred to as inferring cellular networks. One simple
approach to learn a regulatory network is to find the genes that are statistically correlated to each
other in a pair-wise approach. If two genes are correlated then they influence each other. The set
of graphical models is called co-expression networks (Wolfe et al. 2005). In a biological sense,
if two genes show similar gene expression profiles, then they hint at a co-regulation relation-
ships (Markowetz & Spang 2007). However, research has emphasised that in gene expression
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profiles, where the number of genes exceeds the number of samples, p  n, it is important to
find the significance of the amount of correlation, as many pairs of genes show similar behaviour
in expression profiles by chance, even though they are not biologically related (Markowetz &
Spang 2007).
Another set of graphical models is Bayesian networks, which give a useful representation of
probability in a compact way. There are different methods to learn Bayesian networks from
data. Approaches to learning Bayesian networks from gene expression data include: linear rela-
tionship learning algorithms (D’Haeseleer et al. 1999), which are referred to as learning Gaus-
sian graphical models (Geiger & Heckerman 1994a); and non-linear relationships learning al-
gorithms (Weaver et al. 1999). Boolean networks also a popular set of graphical models which
are simple deterministic models of regulatory networks that are defined by a directed, possibly
cyclic, graph. Each gene in the Boolean networks has a Boolean function, which maps the rela-
tionship between the gene and its parents. Causal acyclic graphs have also provided great help in
understanding the causality between large numbers of genes. Learning a causal acyclic network
is similar to learning a Bayesian network, given that causal Markov assumption holds. Thus,
given the values of a variable’s immediate causes, it is independent of its earlier causes.
The interpretation of causality from Bayesian networks has received a great deal of treatment
in the literature (Heckerman et al. 1997; Pearl & Verma 1991; Spirtes et al. 2000). Intervention
that makes some enforced methods, for example, gene knockout is a well known method for
inferring causality networks. Another way of making causal graphs from observations is by only
using causal prior knowledge to learn the parents for each gene. (Murphy & Mian 1999) shows
how regulatory networks can be inferred using dynamic Bayesian networks. However, learn-
ing such networks requires time series measurements for genes at different times. (Murphy &
Mian 1999) shows that most of the proposed discrete time graphical models that include Boolean
networks, both linear models and non-linear models, are all special cases of a general class of
models called dynamic Bayesian networks. Another set of graphical models is dependency net-
works (Heckerman et al. 2000). The graph of a dependency network, unlike a static Bayesian
network, is potentially cyclic. When two genes in a graph are found to be good predictors of each
other, then the dependency networks fit well (Aloraini et al. 2010).
CHAPTER 3
Biology of Cancer
This chapter presents a discussion about cancer in terms of how it occurs and how it is treated.
It focuses on two very common types of cancer, breast cancer and prostate cancer. Section 3.2.1
gives an explanation of what breast cancer is, how it occurs and how it is treated. Section 3.2.2
details prostate cancer, how it occurs and the treatment. The chapter concludes with a detailed
section about cell communication and how the treatment of cancer can be improved using sig-
nalling pathways.
3.1 What is a cancer
Cancer is a disease that is a result of uncontrolled cell growth. When a cell grows/divides uncon-
trollably it stops to respond to the normal signals that control the cell growth (Adami et al. 2002).
Environmental factors play an essential role in cancer development but also cancer might occur
due to heredity (Anand et al. 2008). The beginning of cancer, inside the cell, is dependent most
commonly on a genetic mutation that occurs in the DNA (Deoxyribonucleic acid) (Figure 4.2)
inside the cell. DNA mutation can happen when even a single nucleotide changes in the DNA.
The genetic sequence change leads to production of a mutant protein. However, more commonly,
a normal cell transforms to a cancerous one when several mutations happen inside the DNA in
the cell. These mutations can disrupt the cell’s growth, which in turn leads to the development of
a tumour mass(www.insidecancer.org). Different types of cancer can occur in different
parts of the body, including: breast cancer, prostate cancer, brain cancer, lung cancer and skin
cancer. The cancer can be solid tumours, in which lumps are formed or liquid tumours such as
leukaemia.
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Figure 3.1: A DNA strand with the four nucleotides (lettered A, T, C,and G).
3.2 Overview of Two Types of Cancer
3.2.1 Breast cancer
Breast cancer is an uncontrolled growth of breast cells which can spread to different parts of
the body. Despite the fact that breast cancer occurs when a mutation in the DNA happens,
known as genetic sequence disruption, only 5-10% of breast cancer is inherited, while 90% of
cases are known to be from environmental factors and genetic processes inside the body(www.
breastcancer.org). Figure 3.2 shows the structure of the breast.
Figure 3.2: The structure of the breast inside the body(www.breastcancer.org).
The breast is a gland designed to make milk, which then goes through ducts to the teat.
The cells in the breasts normally grow and rest in cycles, with genes inside the breast cells
responsible for controlling and managing the growth of cells. The nucleus in a cell keeps cell
growth under control, which causes genes to work normally. However, when genes develop an
abnormality, they sometimes lose their ability to control the cycle of cell growth and rest. The
exact causes of breast cancer are not yet known, but certain environmental risk factors have been
defined(www.breastcancer.org):
• Age: getting older, 80% of breast cancer cases occur in post-menopausal women.
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• Nulliparity: having no children or having children late in life.
• Prior history: a significant family history of breast cancer.
• Alcohol: use of alcohol is clearly linked to a slightly increased risk of getting breast cancer.
• Early menarche: menarche before age 12 is a risk factor for certain types of cancers in
women, including breast cancer.
• Being overweight (especially after the menopause).
Generally, breast cancer can be considered in two main categories: benign cancer, sometimes
called non-invasive cancer and malignant cancer (invasive cancer). Non-invasive cancer grows
and divides abnormally inside the breast; but is only in the milk ducts in the breast (Figure 3.2)
and does not spread into the surrounding breast tissue or to other parts of the body. Sometimes
this is called a pre-cancerous condition. However, with invasive cancer, the cancerous cells are
no longer confined to the breast ducts and lobules. They spread to the surrounding breast tissue
and have the potential to spread to other parts of the body. Several statistical studies have reported
that breast cancer is the most prevalent cancer type in many areas around the world (Parkin et al.
2000). The basic kinds of tests conducted on breast cancer patients can be defined as follows:
1. Mammogram: an x-ray examination, designed to detect breast cancer at an early stage.
2. Ultrasound scan: high-frequency sound waves are used to outline the suspicious areas of
cancer.
3. Fine needle aspiration (FNA): a quick and simple procedure which is done in the outpatient
clinic. Using a fine needle and syringe, the doctor can diagnose cancer cells by taking a
sample of cells from the breast lump using FNA.
3.2.2 Prostate cancer
The prostate is a small gland that sits under the bladder and in front of the rectum(Figure 3.3) and
is about the size of a walnut. The tube that runs through the penis that carries both urine and se-
men out of the body also runs directly through the prostate(www.prostatecancerfoundation.
org).
Despite great efforts from doctors, physicians and biologists to treat prostate cancer, there is
still a large chance that it will disrupt the operation of urinary, bowel and sexual functions. For
example, one solution for prostate cancer is to remove the prostate from the body. As a result,
the bladder is pulled downward and connects to the urethra at the point where the prostate used
to sit. If the sphincter at the base of the bladder is damaged during this process or even if it is
damaged during radiation therapy, some leakage of urine might start to occur. Moreover, there
might be an inability to control the bladder and bowels.
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Figure 3.3: The position of prostate cancer.
Prostate cancer is the most common cancer in men. It is highly associated with different risk
factors(www.prostatecancerfoundation.org) such as:
• Age: although only one out of 10,000 under the age of 40 will be diagnosed, with increas-
ing age the rate becomes much higher, up to 1 in 38 men aged 40 to 59 and 1 in 15 of those
aged 60 to 69 will be diagnosed.
• Race and family history: these are some of the most important factors. For example, in
America, African American men are 61% more likely to develop prostate cancer compared
with people of pale skin. Also, a man with a first degree relative such as a father, brother
or son with a history of prostate cancer is twice as likely to develop the disease.
The risk factors mentioned above for breast and prostate cancers are used in many hospitals and
labs to diagnose cancer. However, for the purpose of diagnosis, clinical factors alone are not
always helpful. This is why doctors and biologists have started to pay much more attention to
using other data as well as clinical data.
Figure 3.4: The structure of a cell inside the body.
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Using signalling pathways with clinical factors for cancer treatment has emerged in the last
decade. The cancer is diagnosed from the genomic point of view, based on tracking the com-
munication of cells and genes inside each cell. Cells work together using chemical signals and
therefore the signals are the core of growth, division and death for each cell. A disruption in cel-
lular communication is a strong sign of cancer. Usually, biologists and doctors track the failure
of normal signals in cancer cells by comparing them to cell signalling pathways in the normal
cellular system. In the general case, the signals are transferred from outside the affected cell
into its cytoplasm and then to the cell nucleus (Figure 3.4). In the next section a more detailed
discussion will be given on cell communication. The discussion of cell communication in the
next section is largely based on (Campbell & B.Reece 2005), and (Alberts et al. 2002).
3.3 Cell Communication
Cell-to-cell communication is essential for multicellular organisms. The cell inside the body
must communicate to grow ,divide and reproduce during cell life. Understanding cell signalling
helps greatly to answer important questions in biology and medicine , such as the development
of cancer. The signals received by the cell either comes from another cell or from some changes
in the organisms’ physical surroundings. The communication between cells most often occur by
chemical signals and therefore heavily depend on extracellular signals molecules which are pro-
duced by the cells. Cell-to-cell communication happens by releasing chemical signals/messages
that are targeted for neighbors cells or further away cells. When the chemical messages target
neighbors cells such as molecules they are called local regulators. In this section, a discussion
about the main mechanisms of how cells detect, process and respond to the chemical signals will
be given.
3.3.1 The stages of cell signalling
When a cell receives a signal from another cell , three stages are taken into consideration: sig-
nal reception, signal transduction, and cellular response. When the reception occurs at the
plasma membrane(Figure 3.4), the signal transduction usually a pathway of several steps and
each molecule in the pathway makes change in the next step. Finally, the last molecule in the
pathway causes the cell’s response.
3.3.1.1 Signal reception
The first stage of receiving a signal in the cell , a signal molecule binds to a receptor protein
which causes the protein to change its shape. The targeted cell by a specific signal has molecules
of a receptor protein that recognises that signal molecule. Basically, the signal molecule acts as a
ligand which is a small molecule binds to a larger molecule. The process of ligand binding causes
a receptor protein to change its shape. The result of this shape change will activate the receptor
so that it can interact with another cellular molecule. Moreover, the ligand process might lead
two or more receptor molecules to aggregate together. Most of the signal receptors are proteins
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that are located in the plasma membrane.
3.3.1.2 Signal-transduction pathways
In this stage of cell signalling , multisteps pathway can occur. One major benefit of such pathway
is signal amplification since if some of the molecules in a pathway transmit the signal to multiple
molecules, a large number of activated molecules can happen. Signal pathways receive and send
(relay) signals from receptors to cellular response in which the signal activated receptor activates
another protein, which in turns activates another molecule until the protein that produces the final
cellular response is activated. The molecules that receive and pass a signal from the receptor to
the response mostly are proteins.
In signal transduction pathways, important protein activation/inactivation processes can happen.
One important regulation in cells is protein (de)phosphorylation which is a major mechanism
of signal transduction. A signal pathway starts with receiving a signal molecule that binds to
a membrane receptor protein. Then, the receptor activates a relay molecule which in turn acti-
vates a protein kinase. Protein kinases are enzymes that alter other proteins by adding phosphate
group to them(phosphorylation). After that, activate protein kinase transfers a phosphate from a
nucleoside to active another protein kinase molecule(nucleoside is glycosylamines consisting of
a nucleobase). The activation of the second protein kinase causes the phosphoralation and the
activation of a third kinase. Finally, the activation of the third protein kinase phosphorylates a
protein that stimulates the cell final response to the signal. The dephosphorylation of all protein
kinases can be made by the removal of the phosphoate group by enzymes called phosphatases.
Another important mechanism related to protein molecules during signal transduction is protein
degradation. Protein molecules are continuously synthesised and degraded in all living organism.
The concentration of individual cellular proteins is determined by a trade-off between the rate of
synthesis and degradation. This will lead to loss of proteins from cells(atrophy) or increase in
protein content of cells(hypertrophy). In fact, degradation rates of proteins are essential to their
cellular concentrations.
the transcription of genes also can be seen as a mechanism of protein activation/inactivation.
The amount of gene expression released by a gene can be a sign for the amount of produced
protein. Genes essentially are made up of DNAs which act as structural blocks to produce pro-
teins. In a signalling cell life , genes are transcribed to Ribonucleic acid(RNA), and then RNA
is translated to protein. Often , measuring the amount of activated protein is difficult and there-
fore, measuring gene expressions at the RNA level(downstream/upstream) is used to detect the
activation/inactivation of proteins.
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3.3.1.3 Cellular response to signals
The signal-transduction pathway stage has an ultimate goal which is the regulation of one or
more cellular activates. This signalling pathway regulation will lead to active/inactive specific
proteins by turning specific genes on or off.
3.4 Wnt signalling pathway
After we have given a broad discussion about cell communication and the various protein acti-
vation/inactivation processes that happen during cell signalling communication, this section will
focus on an important pathway known to be involved in many biological processes, namely Wnt
signalling pathway(Figure 1.4,page 21). Wnt signalling pathway has a central role and inap-
propriate activation of this pathway are observed in several human cancer (Spink et al. 2000).
Nevertheless, many of the mechanisms involved in activation/inactivation of this pathway still
unclear (Thorstensen & Lothe 2003).
In the presence of Wnt ligand(wnt signalling) , Wnt ligand binds a Frizzled(FZD) proteins and
a co-receptor protein related to the low density lipoprotein receptor related protein(LRP). This
in turn will activate the cytoplasmic protein dishevelled(Dsh/Dvl). Presicly how dishevelled pro-
tein is activated is not fully understood but phosphorylation by casein kinase1(CK1) and casein
Kinase2(CK2) have been suggested to be partly responsible (Willert et al. 1997; Sakanaka et al.
1999; Amit et al. 2002). The activation of Dsh/Dvl will lead to the inhibition of β-catenin phos-
phorylation and degradation. This mechanism is not fully understood but it requires Dsh/Dvl and
other signalling proteins(Axin, adenomatous polyposis coli (APC), and glycogen synthase kinase
(GSK)-3β) that bind to Dsh/Dvl (Thorstensen & Lothe 2003; Alberts et al. 2002). Dsh/Dvl is
suggested to bind CK1 and thereby inhibiting priming of β-catenin and this indirectly preventing
GSK-3β phosphorylation of β-catenin (Amit et al. 2002). The increase in undegraded β-catenin
caused by wnt signalling allows β-catenin to enter the nucleus and binds to the members of the T-
cell factor(Tcf)/lymphoid enhancing factor(Lef) family(TcF/Lef1). At this stage, β-catenin acts
as a co-activator which induces the transcription of the WNT target genes.
Other genes activated by β-catenin is c-myc that encodes a protein(c-Myc) which is a prime
factor of cell growth and proliferation. However, if a mutation occurred to a protein called APC
that binds to Dsh/Dvl via Wnt-signalling , this will inhibit the ability of c-myc proteins to bind
β-catenin. Therefore,β-catenin accumulates in the nucleus and stimulates the transcription of
c-myc and other target genes. This stimulation can also be observed in the absence of Wnt sig-
nalling. One major cause of this stimulation is uncontrolled cell proliferation that promotes the
development of cancer.
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3.5 Summary
A growing understanding of the complex signalling pathways that underlie tumour formation
and progression is aiding the development of a new generation of anti-cancer drugs, targeted at
specific molecular events. For example, the Wnt signalling pathway is known to participate in
prostate cancer development (Birnie et al. 2008) and studying this pathway in both normal and
abnormal behaviour will potentially enhance our understanding, and allowing the development
of more effective drugs. Recently, databases have been created to present the latest discoveries in
new interactions between pathways and the families of genes in each pathway. One well known
database is KEGG (Kanehisa & Goto 2000; Kanehisa et al. 2010), a collection of manually drawn
pathway maps, representing the latest knowledge on the molecular interaction and reaction net-
works in cancer and other diseases. Using a computerised knowledge-base makes it possible to
track the latest discoveries in molecular networks and unify effort towards a better understanding
of cancer from a molecular level, in addition to the clinical/environmental factors.
The success of KEGG and other projects such as the Human Genome Project have resulted in the
discovery of many genes that are associated with certain diseases such as cancer. However, our
understanding of molecular mechanisms is still incomplete for cancer, which is a combination
of various genetic and environmental factors (Kanehisa & Goto 2000). Therefore, the analysis
of cancer signalling pathways, and in particular the genes involved in these pathways, will better
clarify the molecular mechanisms of cancer and help to develop new drugs and treatments in the
future.
CHAPTER 4
Microarray technology and gene expression profiles data
analysis
This chapter presents a discussion about microarray technology and gene expression profile
data analysis. Section 4.1 begins by showing how messenger RNA (mRNA) is used to mea-
sure gene expression from Deoxyribonucleic acid (DNA). It then highlights the main through-
put DNA-microarrays that are widely used to measure gene expressions. Section 4.3 discusses
the Affymetrix single microarray platform in detail. It shows how the pre-processing steps are
conducted to generate gene expression profiles from a single microarray (Section 4.4). In Sec-
tion 4.4.2, the pre-processing steps for the prostate cancer datasets that are used in this work are
given. In Section 4.4.3 and its subsections, refined pre-processing steps for the genes included
in the Wnt signalling pathway are presented. Section 4.4.4 introduces the gene expression colon
cancer datasets pre-processing steps that are generated from the Illumina microarray platform.
4.1 Introduction
Almost every cell in the body of an organism has the same DNA. Genes essentially are made up of
DNAs that act as instructions to make molecules called proteins. Genes are expressed using two
steps, first they are transcribed into RNA (Ribonucleic acid) and then the RNA is translated into
the corresponding protein, Figure 4.1. There are three types of RNA: messenger RNA (mRNA),
transfer RNA (tRNA) and ribosomal RNA (rRNA). Biologically, RNA is an important type of
molecule, consisting of a long chain of nucleotide units. All DNA microarray platforms are
being developed based on transcribed step RNA and in particular on messenger RNA (mRNA)
as it is the most important type of RNA. The name messenger RNA suggests that it carries the
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information encoded in DNA to the translation step protein, as each DNA becomes a protein.
Figure 4.1: DNA is transcribed to mRNA and then translated to protein
4.2 DNA-microarrays
Deoxyribonucleic acid(DNA) is described as a nucleic acid that contains the genetic instruc-
tions for living organisms. It is a double helix(Figure 4.2) and each side helix are formed by
a backbone sugar and phosphate molecule. The two helix are connected by four nucleotide
bases joined weakly in the middle by hydrogen bonds. Thus, Adenine base(A) is bound with
Thymine(T), whereas Guanine base(G) is bound with Cytosine(C). Therefore, the strands of the
helix are complement to each other. All DNA-microarrays are built using this chemical fact of
complementarity. DNA-microarrays(Figure 4.3) consist of many single strands of DNA attached
to their surface that are known as probes. When the complementary strands for the probes on
the surface of microarray are spread on the surface, the hybridization process happens which is
the result of sticking each strand to its complementary on the surface of microarray. Microarrays
measure the amount of hybridization at the mRNA level which is the transcriptional step before
a gene translated to a protein, Figure 4.1. mRNAs carry the DNA’s genetic message to the cy-
toplasm of a cell where proteins are made. A strand of mRNA is similar to a strand of DNA
except that DNA has A,T,C,G nucleotide bases but RNA instead of Thymine(T) it has uracil (U).
Therefore, the purpose of microarrays is to measure for each gene in the genome the amount of
message that is carried by mRNA and if mRNA can find its complementary in the array surface
then it binds naturally and sticks to a particular spot in the array.
Currently, different DNA-microarrays are used to measure thousands of genes in one go.
Affymetrix one-channel microarrays, two-channel microarrays and Illumina microarrays are ex-
amples of microarray technologies currently used in many labs. In this work, the focus is on
one-channel microarrays and Illumina microarrays. The comparison between different gene ex-
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Figure 4.2: DNA is a double helix formed by base pairs attached to a sugar-phosphate backbone.
Figure 4.3: DNA-microarray
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pression profiles generated from all microarray technologies are based on the amount of mRNA
shown from each gene in different conditions. For example, the expression level of a gene in
cancer tissue is compared to the expression level for the same gene in a non-cancer tissue.
Although DNA-microarrays are widley used in many labs for new biological discoveries , they
have their limitation. The limitation of DNA-microarrays comes from mRNA measurements.
Generally speaking, microarrays are used to find out the protein activation/inactivation via mea-
suring mRNA released from a gene to the cytoplasm of a cell. This is a more stable process and
possibly easier than measuring proteins in the translation step of a gene in the cytoplasm. How-
ever, for different reasons a gene might release mRNA but a defect in the cell might prevent that
gene from being translated to protein , for example in cancer cells. DNA-microarrays can not
detect this defect and might show an amount of gene expression at the mRNA level but still it will
be questionable whether this gene is being translated to a protein. A more advance technology
called protein expression analysis can be used which can tell whether a gene has been translated
to a protein after an amount of mRNA is detected by DNA-microarray. However, protein iden-
tification and quantification technologies still far away from the high-throughput experimental
techniques used to determine mRNA expression levels (Greenbaum et al. 2003).
4.3 Single-channel Microarrays
Single channel microarrays, of which the Affymetrix system is the most popular, are used to
measure the expression levels of thousands of genes in parallel. They can be used for one-time
experiments or time-series experiments, used for instance to measure a gene expression in dif-
ferent time under one condition. Affymetrix microarrays have been developed to generate gene
expression profiles by measuring the signal intensity, the amount of hybridisation, of fluoresc-
ing molecules that are attached to DNA (which are reverse-transcribed from extracted mRNA or
genomic DNA) that are bound to the complementary strand probes localised on the surface of
the microarrays. Each localised probe in Affymetrix microarray is distinguished by a probe-id,
which is used usually after the hybridisation to map each probe to a gene name. The design
of Affymetrix experiments ,to obtain gene expressions, consists of three steps:(i) identifying the
conditions of interest ,for example we are interested in comparing the healthy cell against a can-
cerous cell (ii) obtaining biological replicated of each condition, and (iii) preparing the hybridiza-
tion sample. Preparing the hybridization sample includes preparing the surface of the chips by
injecting the fragment of complementary DNA (cDNA) for each gene, for each condition, in each
spot of the microarray (Wit & McClure 2004). However, the results of Affymetrix experiments
are not in the final format for further analysis. The result of the hybridisation in each chip is a
pixel file (CELL file), which has probe-sets intensities that go through different normalisation
steps. Each gene in Affymetrix microarrays is represnted with replicated probes,hence probe-set,
and typically 11-20 probes are represented on a microarray for each gene. The fregment of a
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gene usually 25 base pairs long and what might happen naturally is that mRNA from other genes
may find parts on common with individual probe and attach itself to that probe. To overcome this
problem, Affymetrix platforms have what is called mismatch probes(MM) which are obtained
by changing the 13th base pair in the fregment of the gene localized in each spot in addition to
the canonical probe(a section of the mRNA molecule of interest) ”perfect match”(PM) for each
gene. To obtain one single gene expression for any gene , the probe set has to be summarized as
we will discuss in the next section.
Generally in single channel microarrays, a biologist is usually interested in a comparison be-
tween two conditions, for example, healthy genes compared to cancerous genes. However, it is
not possible to use a single-channel microarray for more than one condition. Therefore, if two
samples/conditions are used, the biologist needs two single-channels for each sample/condition.
The number of samples and conditions are solely dependent on the number of microarray chips
available. Since a single chip can measure thousands of genes in parallel, usually having many
chips (samples) comparing to genes number is very expensive and therefore the resultant gene
expression profiles are usually exposed to the problem of large variables (p), small samples (n).
In the next section, we will go through the pre-process steps for generating gene expression pro-
files from single-channel microarrays. Then, we will apply it to row data (CELL files) appeared
in (Birnie et al. 2008) that we will use throughout the next chapters.
4.4 Pre-processing Steps for Generating Gene Expression Pro-
files
Several methods have been proposed to normalise and pre-process Affymetrix raw data stored in
a CELL file. For example: MAS 5.0, dChip (Li & Wong 001a) and robust multichip average
(RMA) algorithms (Irizarry et al. 003a) are well established methods for normalisation. Mainly
, one can view the differences between MAS 5.0, dChip, and RMA algorithms in terms of probe
intensities summarisation. MAS 5.0 algorithm computes the probe set intensity signal as the anti-
log of a robust average of the values log(PMij − CTij) where CT is equal to MM when MM
< PM but adjusted to be < PM when MM≥ PM to non-negative summarised probe set signal
values (Saviozzi & Calogero 2003; Wit & McClure 2004). So, a model for MAS 5.0 probe set
intensity measures is :
log(PMij − CTij) = log(θi + ij), j = 1, ..., J
Therefore, the expression value for a probe set on any array(i) is given by θi and an error
term ij that represents the variance for j = 1, ..., J probe-set spots. The dChip algorithm also
calculates the probe set intensity based on the difference between the perfect match(PM) probes
and mismatch(MM) probes using multiplicative model:
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PMij −MMij = θiφ+ ij , i = 1, ...I, j = 1, ..., J
The dChip algorithm is based on the observation that the variation of a specific probe across
multiple arrays could be smaller than the variance across probes within a probe set , which indi-
cates a strong probe affinity effect (Li & Wong 001b).
On the other hand, RMA algorithm is based only on perfect match(PM) probes and uses an-
other way of finding the correct summarised signal represented for each probe set intensity. The
probe set model in RMA algorithm can be given generally as follows :
T (PMij) = ei + aj + ij , i = 1, ...I, j = 1, ..., J
Where T is multistep procedure conducted on probe set intensities which includes : background
correction, quantile normalisation , and logs PM intensities, ei is the log2 scale expression value
found on array i=1,...I and aj is the log scale affinity effects for probes j=1,...J. (Irizarry et al.
003a) gives a comparison of RMA to the dChip and MAS 5.0 algorithms and shows that RMA
has a better precision than MAS 5.0 and dChip. According to that , in this work we will use
RMA algorithm to normalize the probe intensities data that we will use throughout this thesis. In
the next section, a detailed section about the three steps of RMA algorithm will be given.
4.4.1 The normalization of probe set intensities using RMA Aglrothim
In this section , we will explain the RMA algorithm for normalisation which is based on perfect
match(PM) probes , as it is well established and widely used in Affymetrix data normalisa-
tion (Barash et al. 2004; Laurent et al. 2004; Schlecht et al. 2004; Abeyta et al. 2004; Scott et al.
2004; Tsuchiya et al. 2004; Parmigiani et al. 2004; Barczak et al. 2003). It consists of three steps:
background adjustment, quantile normalisation and summarisation (Bolstad et al. 2003; Irizarry
et al. 003a,b).
The background adjustment/correction is used to make sure that the values obtained from the
surface of a microarray when it is scanned for pixel intensities correspond to the amount of
mRNA expressed. Figure 4.4 shows an example of how the background might affect the true
mRNA signal.
The background corrected intensities are computed in such a way that all background-corrected
values must be positive. After the background correction, base-2 logarithm is used for each back-
ground corrected value.
The second step in the RMA algorithm is quantile normalisation. Normally in the lab the exper-
iment is replicated many times using different populations. For example, it might use different
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Figure 4.4: Background signals attached to the true mRNA signals in the surface of a
chip (Yukhananov & Loguinov Yukhananov & Loguinov).
samples from different patients under one condition. The goal is to obtain one gene expression
profile for all genes (n) across all samples (p) given one condition. Therefore, shift and scale
parameters are used to remove the systematic differences between the different arrays (Wit &
McClure 2004), called normalisation across arrays. Different methods to deal with different
measurement scales from different arrays have been proposed. These methods transform the data
by bringing the mean intensity for each array to some fixed quantity and scaling it to a fixed
value (Kerr et al. 2000; Yang et al. 002b; Wolfinger et al. 2001). The choice of shift and scale
parameters are largely arbitrary. The most common ones are the mean for shift and standard
deviation for scale. The main objection to using this global method for removing systematic
differences across samples is that it does not take into consideration the differences between ar-
rays due to different environmental factors for each population used in each array (samples). For
example, in an experiment using healthy patients as samples, each patient might be exposed to
factors that affect their genetic profile; therefore, there might be a gene in one patient that is up-
regulated but which is down-regulated in another patient. Using a global method will discretise
this difference into a shifted and scaled value that might make these two patients have the same
gene expression values. The global method has the intuition that given that the same genes are
measured under one condition, such as healthy patients or cell lines, it is expected that the gene
expressions values are similar in all cell lines under the same condition, which is not always
true (Wit & McClure 2004).
Quantile normalisation is proposed to deal with the limitations encountered in the global method
discussed above. Quantile normalisation includes transforming all the replicates for each gene
(in the probe-level) into the same scale. The scale is attained by using the overall mean of the
probe intensity distributions of all the replicates, which makes the distribution identical across
arrays (Bolstad et al. 2003). Before the data is scaled using the mean of the replicates, an ar-
Section 4.4 Pre-processing Steps for Generating Gene Expression Profiles 55
rangement to the probes across the arrays is made. This is done by ranking the probe values
in each array incrementally and then taking the mean across the arrays. For example, if we
have two vectors representing five spots and two replicates: X1 = [16, 0, 9, 11, 7] and X2 =
[13, 3, 5, 14, 8]. First, the rank for each probe in each array is taken Xranked1 = [5, 1, 3, 4, 2] and
Xranked2 = [4, 1, 2, 5, 3]. Then each vector is ordered X
ordered
1 = [0, 7, 9, 11, 16] , X
ordered
2 =
[3, 5, 8, 13, 14]. Next, the mean for each two ordered probe across samples is taken X¯ =
[1.5, 6, 8.5, 12, 15]. Finally, we map Xrankedi to X¯ and each probe quantile is normalised in
each spot of the array Xnorm1 = [15, 1.5, 8.5, 12, 6.0], X
norm
2 = [12, 1.5, 6.0, 15, 8.5].
This method is also able to deal with non-linear relationships and by using the scale as the mean
of all the distributions of all the replicates, it is hoped that the resultant distribution for each gene
is a better reflection of the gene transcription (Wit & McClure 2004).
The last step for normalising gene intensities is summarisation. When the probe-levels are
background corrected and normalised, each gene expression is still in the base of the probe-set
in each spot. The gene measurements need to be summarised into a single number, representing
a gene expression value in each spot (Irizarry et al. 003b; Bolstad et al. 2003). The probe-sets
in each spot are identical pieces from the same DNA and are supposed to bind to the same
complementary DNA (cDNA). Therefore, the signals or the intensities we get in the CELL file
are probe-set intensities. The probe-sets are used in the hybridisation process, because more
accurate results can be obtained, rather than relying on one piece of probe for hybridisation.
4.4.2 Pre-processing prostate cancer datasets from Affymetrix microar-
rays
This section presents the result of pre-processing the prostate cancer datasets that are used for
further analysis in the chapters below. The focus on prostate cancer is based on (Birnie et al.
2008), which uses Affymetrix microarrays (Affymetrix GeneChip Human Genome U133 Plus
2.0) to generate the hybridised probes (.CELL files). The aim of this study was to identify genes
that have significantly different expressions in stem cells from those in committed basal cells.
Samples from both prostate cancer samples and benign controls were used. The RMA algorithm
was used for normalisation and the result was four complete datasets, without missing values.
Furthermore, 38 samples were used in the experiments, of which 19 samples were stem cells
(SC), and 19 were committed basal cells (CB). When these four datasets were mapped to the
KEGG database, the gene expression signatures were found to be enriched for genes from four
main pathways: JAK-STAT signalling (Figure 4.5), Wnt signalling (Figure 1.4,page 21), the cell-
extracellular matrix interaction pathway (Figure 4.6) and the focal adhesion signalling pathway
(Figure 4.7).
As it becomes increasingly apparent that studying a small numbers of genes in isolation does
not provide a sufficient understanding of the higher order systemic processes that regulate cell
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Figure 4.5: The JAK-STAT signalling pathway [Kanehisa Laboratories, 2009]
growth, researchers are becoming interested in finding methods that provide a picture of how each
gene in a pathway interacts with those around it. There is no existing mechanism for accessing
the specific connections between gene families that underlie the generic connections represented
in the KEGG signalling diagrams. For example, the Wnt signalling pathway in Figure (1.4), page
(21) shows that WNT directly interacts with Frizzled (FZD). However, there are 19 WNT and
10 FZD proteins listed in the KEGG database and KEGG does not show which member of the
WNT family interacts with which in the Frizzled family.
After obtaining the result in Table 4.1, we concentrated on each pathway separately for the re-
fining process. In this study, the result is based on the Wnt signalling pathway. The methods
developed were then used to refine the other pathways.
The results in Table 4.1 were obtained by using different Bioconductor and R software pack-
ages. First, two libraries were loaded, hgu133plus2.db, which is a package corresponding to
the Affymetrix microarray used in the experiments, and KEGG.db which is used for search-
ing KEGG pathways to find the targeted pathways. When the RMA algorithm normalises the
datasets, the result initially has probes that are irrelevant to the study, for example, some probes
have no gene name annotations, since they are control probe IDs. Therefore, to get the probe
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Figure 4.6: Cell-extracellular matrix interaction signalling pathway [Kanehisa Laboratories,
2009]
Table 4.1: Each pathway and its dataset
Pathway Number of Samples Number of Probes
Wnt signalling 451 probes
JAK-STAT 38 samples (19 SC,19 CB) 398 probes
Cell-extracellular matrix interaction 291 probes
Focal adhesion signalling 705 probes
IDs that have annotations, hgu133plus2.db was used to map the probe IDs to gene names. The
KEGG.db package was then used to extract the probe IDs and gene names that are only in the
four KEGG pathways we will focus on.
4.4.3 Wnt signalling pathway datasets
Since each dataset contains both cancer and non-cancer samples, it is essential to separate them
further, because we want to understand how the cellular system works in cancer and non-cancer
samples separately. The first thing we considered was separating the dataset into four different
cell types: cancer stem cell, cancer committed basal cell, benign stem cell and benign committed
basal cell. Each one was then treated individually, as shown in Table 4.2.
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Figure 4.7: Focal adhesion signalling pathway [Kanehisa Laboratories, 2009]
Table 4.2: Wnt signalling Pathway Dataset.
Cell Type SC dataset CB dataset
Cancer 451 probes,13 samples 451 probes, 13 samples
Non-cancer 451 probes,6 samples 451 probes, 6 samples
4.4.3.1 Pre-processing stem cells (SC) in the Wnt signalling Pathway.
The stem cell dataset is used because it has more samples than the committed basal cell dataset.
Moreover, since we are not interested in this thesis in differential gene expressions that happen
between different conditions(cancer and non-cancer samples) nor between different cells(stem
cells and committed basal cells) , we will focus on genes that show expressions. Genes that
are unexpressed/down-expressed are discarded, Thus, there is a chance to reduce the dataset fur-
ther. The question then becomes how to distinguish unexpressed/down-expressed genes from
expressed or over-expressed genes. The sensitivity limits of the detection system mean that ex-
pression values < 50 are considered unexpressed/down-expressed. This corresponds to the value
5.64 in the gene expression profiles used here, since log2 is used after the background correc-
tion method in the RMA algorithm. Thus, we can use the following logic: IF gene value <
5.64, THEN it is excluded. Furthermore, since we are interested on genes that show expres-
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sions , the gene that falls below the threshold used here(< 5.64) in more than or equal half of
the samples(<= 13/2) , will be discarded from the data. In fact, from machine learning point
of view , all these pre-processing steps have been used to make overfitting problem less harmful
as we will discuss in more details in chapter 6 . Based on this criterion, the SC dataset becomes
smaller(212 probes out of 451 genes are kept in the SC cancer samples), and more importantly,
contains fewer genes, which in turn reduces the possibility of overfitting or what is known as the
p n problem, as we only have 13 samples. Therefore, when we learn a graphical model from
this data in the next chapters , all the genes represented in the graph have shown expressions
in the Affymetrix experiments and so the detailed KEGG pathways will be based only on the
expressed values of genes used in the experiments.
We started by looking at a group of components that react together. Therefore, we extracted
the upper left part of the Wnt signalling pathway, Figure 4.8, whose components are known from
KEGG to react with each other. Table 4.3 shows the dataset of the 1st block from which cancer
samples used in this study were taken.
Figure 4.8: The first part of the Wnt signalling pathway.
Table 4.3: The SC dataset (cancer and non-cancer) for the 1st part of the Wnt signalling pathway.
Cancer Non-Cancer
25 probes,13 samples 25 probes, 6 samples
4.4.4 Pre-processing colon cancer datasets from Illumina micorarrays
This section details a short experimental study carried out at King Abdullah International Medical
Research Center (KAIMRC). It was based on using Illumina microarrays to explore the effective-
ness of 4 treatments on 5 colon cancer cell lines (5 samples), in comparison to untreated colon
cancer cell lines. The cell lines are HCT-116, HT-29, RKO, HCT-8 and Gc3/c1. The therapies
used for treating colon cancer cell lines are:
• F:5-Fluorouracil + Leucovorin
• A: Interferon - Alpha
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• G: Interferon - Gamma
• F+G: Interferon - Gamma + 5-Fluorouracil (F) + Leucovorin
The Illumina microarray (Illumina BeadArray) is a relatively new type of microarray for gen-
erating gene expression datasets. It has been repeatedly evolved in biological labs alongside with
Affymetrix microarrays. A comparison study between these two types of microarray (Barnes
et al. 2005) shows that for the purpose of spotting the differential gene expressions between
two conditions, the two platforms find the same genes that are differentially expressed. How-
ever, the statistical methods for analysing Illumina data are still far from those methods used for
Affymetrix and need to be improved (Xie et al. 2009).
To pre-process the data generated from the Illumina BeadArray we used Illumina BeadStudio
software. The pre-processing or normalisation involves two steps: background correction and
quantile normalisation.
The background correction method used in BeadStudio is called background subtraction.
Background subtraction assumes that the total (S) signal (intensity) which comes from the chip
for each spot has some noisy signals (B) (background signals). The true signal (T)=S−B. There-
fore, the result will have positive and negative values, based on whether the gene is expressed
or unexpressed. A normal scenario after background correction is to use log2 for variance-
stabilising transformation, but with negative values this will not be possible, a drawback which
is reported in the literature (Xie et al. 2009). For the gene expression datasets that we used, the
view was that the negative values should be excluded, either because they were noisy or had
low expression values. We used this step, since the aim was to keep only the genes with high
expression values. This was for two reasons, firstly, we only had five samples, so we needed to
cut off the dimensionality of having a lot of genes and small sample sizes. The second reason
was that we are interested in the most important genes; therefore, a compact picture of how high
expressed genes work in different treatments vs the control (untreated) cell line can be observed.
This will also allow us to use log transformation for variance stability and also more linear re-
lationship can be observed. After the data from Illumina is background corrected and logged,
quantile normalisation is used as a final step for pre-processing. We used the same cut off value
(IF gene value < 5.64, THEN it is excluded) as used in Affymetrix, in order to keep the
highly expressed genes in the datasets. The result is 5 complete datasets, 4 treated and 1 un-
treated, without any missing values.
Each treated and control gene expression profile was then mapped to the KEGG database. We
restricted the search in KEGG to colorectal cancer pathways and found that a large proportion of
the genes in each treatment were annotated in two well known colorectal cancer pathways, the
MAPK signalling pathway and cell cycle pathway. Figure 4.9 shows how many genes are found
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annotated in each colorectal cancer pathway in KEGG and we can see that a large proportion of
genes are found in the MAPK and cell cycle pathways. In Chapter 6, we detail how we used the
methods developed to learn refined MAPK and cell cycle pathways, based on the genes we have
in each treatment and this will show how the behaviour of each treated cellular system changes
after applying each treatment, compared to the control cellular system.
After we have obtained two sets of normalised datasets, we can proceed to explore and de-
velop a method that can effectively show meaningful results. The next chapter will show the first
attempt to learn the genes relationships between the genes involved in prostate cancer, shown
in Table 4.3 using existing tools. Chapter 6 will show a different approach to the problem of
learning graphical models, beyond the existing tools. The method developed will then be used to
learn complete graphical models from prostate cancer datasets, as well as colon cancer datasets.
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Colon cancer pathways names
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Figure 4.9: Colorectal cancer pathways and the number of genes annotated in each pathway
CHAPTER 5
Learning refined graphical models for KEGG pathways using
existing tools
In this chapter, existing tools are investigated in order to learn Bayesian networks from the data
in Table 5.1. Each tool was used with natural prior knowledge from the KEGG database, found
to be useful in minimising the search space. Section 5.6 gives our conclusions and shows the
drawbacks encountered with the tools that were appraised in this chapter.
5.1 Introduction
After focusing on the four pathways and then narrowing the focus to the Wnt signaling pathway,
we took a further step to concentrate on the first part of the Wnt signaling pathway, as shown in
Figure 4.8. For the dataset associated with the first part, we separated stem cells (SC) from com-
mitted basal cells (CB). Furthermore, the cancer and non-cancer samples were also separated.
The work in this chapter is based on the cancer dataset shown in Table 4.3, which has the format
shown below in Table 5.1.
This chapter shows the first work undertaken to extend the representation of the first block of
the Wnt signaling pathway to involve more details about the cellular system interaction between
genes. The set of graphical models used in this chapter are Bayesian networks learning algo-
rithms from discrete and continuous data sets.
Before we introduce the first Bayesian network learning algorithm, we need to formalise
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Table 5.1: Part of the cancer dataset(stem cell samples) for the first part of the Wnt signaling
pathway.
219483-s-at 205990-s-at 213425-at 231227-at ....2205606-at
PORCN WNT5a WNT5a WNT5a ....LRP6.1
8.86058 9.35868 8.84773 7.34806 ...8.16661
8.2727 8.97303 7.91203 5.65153 ...7.09921
the dataset to generate a readable network. The part of the first block in Table 5.1 shows the
probe IDs that correspond to genes. Since we like to see the network showing gene names in the
nodes, the probe IDs have been dropped. But this is not a straightforward task, as some genes
have several different probe IDs. For example, WNT5A has three different probe IDs and if we
dropped the probe IDs for this gene, this might cause confusion for the learning algorithm when
it comes to representing the relationship between different WNT5A probe IDs and other genes.
One way to avoid this is to give the probe IDs that correspond to one gene different notations,
such as WNT5A, WNT5A.1 and WNT5A.2. Therefore, the new dataset is as shown in Table 5.2.
Table 5.2: The dataset after the probe IDs have been dropped
PORCN WNT5a WNT5a.1 WNT5a.2 ....LRP6.1
8.86058 9.35868 8.84773 7.34806 ...8.16661
8.2727 8.97303 7.91203 5.65153 ...7.09921
As shown below, this method helps to evaluate the learning algorithm. For example, when the
generated network contains a part like the one in Figure 5.1 we can conclude that this algorithm
works in the right way, because it recognises that these genes should come together, as they
are the same genes for different probes. However, doing this will not allow other genes to be
examined, since once any of the wnt5a genes is chosen as a predictor, it will be enough and
this will not show any improvement for any other genes outside the wnt5a family to be parents.
Moreover, the reason that we did not average them to one value is that, as seen below, although
they are all represent the same gene, they have different relationships with other genes. Hence,
the biologist can see more details about these different probes and the interactions they hold.
5.2 WEKA: Machine Learning Software
The first tool we will use is Weka (Hall et al. 2009), which is open source software with a col-
lection of machine learning algorithms. Since we are dealing with graphical model learning
algorithms, we will look at a specific algorithm in this tool. The K2 algorithm that is a Bayesian
method for the induction of probabilistic networks (Cooper & Herskovits 1991). It is a heuristic
search algorithm guided by a score function which adds parents to the child until its score does
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Figure 5.1: WNT5A probes interaction.
not change. The score function evaluates how well each network fits a given dataset. The search
returns the network with the highest score.
Before turning to the tool, there are requirements that have to be met when the K2 algorithm
is used. Firstly, the dataset used has to have ordered variables. We have to assume ordering
between variables. This means that if the dataset has three variables D = [X1, X2, X3], then
the search space of all possible networks has a size of 8 networks(2n), where n the number of
variables, since each variable has possible parents from the variables preceding it in the order.
Figure 5.2 shows the possible networks from dataset D. In this way, the search space has been
Figure 5.2: All possible networks generated by K2.
reduced to 8 networks instead of 25. Table2.1(Chapter 2,page33) shows all possible networks
for different sizes of datasets, when the assumption of ordered variables is not made. However,
even with ordered variables there are exponentially many Bayesian networks in the search space,
if the parents set for each gene are not limited.
To meet the first assumption, we require background knowledge and the background knowledge
from Figure 4.8 is used. This representation reveals the following:
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1. The PORCN component indirectly affects the WNT component.
2. The Cer-1 component inhibits the WNT component.
3. The Wif-1 component inhibits the WNT component.
4. The FRP component inhibits the WNT component.
5. The Dkk component inhibits the LRP65/6 component.
6. The WNT component activates the Frizzled component.
7. The Frizzled and LRP6/5 components bind to each other.
However, after consulting the database of KEGG pathways that underlie the KEGG diagrams,
it was clear that the diagram in Figure 4.8 has a limitation in its presentation. It shows that
Frizzled and LRP6/5 are dependent on each other (binding to each other in biological language)
but the database underlying it shows more; Frizzled activates LRP6/5 but LRP6/5 does not in-
fluence Frizzled. Therefore, we chose the database as a source of prior knowledge rather than
the diagrams. Furthermore, as we are interested only in genes that are expressed, the Cer-1-
component and the Wif-1 component were removed from the dataset, because they were not
expressed (genes value < 5.64). Accordingly, the final prior knowledge used was:
1. The PORCN component indirectly affects the WNT component.
2. The Dkk component inhibits the LRP65/6 component.
3. The FRP component inhibits the WNT component.
4. The WNT component activates the Frizzled component.
5. The Frizzled component activates the LRP6/5 component.
Therefore, one possible partial order is: PORCN—WNT—DKK—FRP—Frizzled—LRP5.6.
We will treat this partial order as a full order to the dataset, as is required by the algorithm. The
second requirement is for the dataset to have discrete values. The dataset we have comprises
continuous gene expression values and therefore, to adapt the dataset to be acceptable by the K2
algorithm in Weka, the dataset was discretised before using it. (Dougherty et al. 1995) describes
different ways of choosing the best discretisation method; we made a natural discretisation, using
biologists in the lab. The suggestion was to plot the histogram of the dataset as in Figure 5.3
which then tells us how to choose the best intervals.
One choice, based on the histogram in Figure 5.3 could be as follows:
If(Gene < 5.6)THEN(”very − low”);
Else
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Figure 5.3: A histogram of the dataset shows in x-axis the values of gene expressions and in
y-axis the frequency of each interval of values.
If(Gene >= 5.6 AND Gene <= 7.9)THEN(”low”);
Else
If(Gene >= 7.9 AND Gene <= 9.9)THEN(”medium”);
Else
if(Gene > 9.9)THEN(”high”);
Figure 5.4 shows a snapshot of the discretised dataset and Figure 5.5 shows the resultant Bayesian
network.
5.2.1 Discussion
From the network shown in Figure 5.5 we see that there are a few isolated nodes; for example,
wnt3, wnt6 and wnt10b. There are several reasons for this incomplete network. Firstly, the logic
we used to discretise the dataset did not fulfill expectations, because the values of the uncon-
nected nodes do not help to find any patterns. To illustrate this, if we look at the wnt3 values,
we can see that they are all low. Thus, it is very difficult to find a relationship that supports these
values with any other genes and also this can be seen in genes wnt6, and wnt10b . Secondly,
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Figure 5.4: A snapshot of the discretised dataset.
Figure 5.5: The resultant Bayesian network from the K2 algorithm.
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the dataset consists of just 13 samples, which is another barrier to finding useful patterns be-
tween the genes in the dataset. There are other methods for better discretisation, for example,
supervised discretisation or unsupervised discretisation might result in better networks. These
methods would allow us to refine the discretisation process to accept more categories (bins or
intervals); examples are, Equal Interval Width and Entropy-based partitioning (Dougherty et al.
1995). However, after searching the literature and obtaining the results from the K2 algorithm, it
is clear that any kind of discretisation method will yield a loss of information, especially when
the dataset is small.
Additionally, if we labelled the classes as cancer and non-cancer, it is likely that the classifi-
cation information would be lost by partitioning, as a result of combining values into the same
partition. The same principle can be seen in our dataset, where genes with high expression levels
might be lost by combining them with normal or even low expression levels. Therefore, in the
next sections the dataset is used without discretisation.
5.3 The Bayesian Network Wizard Tool
The result from the Weka tool yields loss of information because discretisation causes such prob-
lem, poor patterns between genes and, more importantly, combines different genes with different
significant values into one interval. In this section, we will use the Bayesian network wizard tool
(BNW) (Ferrazzi et al. 2007) to generate a Bayesian network from the dataset in its original form.
Thus, the dataset will be used without discretisation. The different advantages and disadvantages
of the tool during the experiments will be addressed. This tool can learn a Bayesian network from
any type of data (discrete/continuous, static/dynamic). For our current purpose, we will focus on
learning from continuous, static data, due to problems with discrete data which are discussed in
detail above. However, we show briefly in Figure 5.6 that the resultant network from BNW tool,
using discrete data, is worse than the one given by the Weka tool.
One explanation of Figure 5.6 is that no patterns were found between the genes except for
two genes. Again, this was expected, since we do not have much data to support the learning.
Also, discrete data cannot be used with the dynamic option in the tool, due to memory capacity.
The tool shows a message that the dataset should have, at most, 20 variables to use this type of
learning; however, we have 25 variables. Moreover, choosing dynamic learning requires that the
measured gene expression values in the dataset should be taken at different times; for example
t1, t2, t3 but the measurements that we have in the dataset were taken in one-time. Therefore,
the only options that satisfy the situation are continuous with static data. Using this tool requires
the assumption of multivariate normal distribution. Thus, the dependency of each variable on
its parents is a linear combination of the non-linear functions of the parents values, as shown in
equation (5.1):
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Figure 5.6: The resultant discrete Bayesian network from BNW tool.
µi = βi0 +
p∑
j=1
βijΦ(xij) (5.1)
and Φ(.) set to tanh(αx), where α is a predefined parameter.
To choose a network from the search space, a Bayesian model is used to select the best
network, so the search will return the network with maximum posterior probability:
P (Mh|D) ∝ P (Mh)P (D|Mh)
Where:
P (Mh|D) is the probability of a Bayesian network, given the data.
P (Mh) is the prior probability of the network.
P (D|Mh) is the marginal likelihood.
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An assumption of ”equally likely for all models” is applied. Therefore, searching for a
Bayesian network with maximum posterior probability is equivalent to searching for one with
the maximum marginal likelihood. The scoring function of the local marginal likelihood is given
in (Ferrazzi et al. 2007) as follows :
P (D|Mhi) = 1(2pi)n/2
(det(R)i0)1/2
(det(R)in)1/2
Γ(vin/2)
Γ(vi0/2)
(vi0σ2i0/2)
vi0/2
(vinσ2in/2)vin/2
(5.2)
Where Ri0 = the identity matrix,Rin=Ri0 +XTi Xi, v= the sample size,σ
2= the variance.
The search strategy used here is the K2 algorithm. Thus, an ordering is assumed between vari-
ables. This algorithm evaluates models of increasing complexity, as long as there is a gain in the
marginal likelihood and stops when adding parents does not increase the scoring function. To
reduce the risk of finding suboptimal models, a stepwise search has been implemented. The old
marginal likelihood is not only compared with the marginal likelihood of the model when the
new parent which increases the score is added, but also with the marginal likelihood values of
the models with the new parent and when one of the old parents is removed. Figure 5.7 shows
the resultant Bayesian network from the Bayesian network Wizard tool.
Figure 5.7: The resultant Bayesian network from the BNW tool using a continuous dataset
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5.3.1 Discussion
In Figure 5.7, some genes are represented with more than one variable, because the same gene is
assigned to different probes. For example, wnt5a was labelled (3 times) as wnt5a, wnt5a.1 and
wnt5a.2 and wnt7a was labelled (twice) as wnt7a and wnt7a.1. Since these genes are basically
the same, we expect them to be close to each other. The Bayesian network in Figure 5.7 shows
that wnt5a genes and wnt7a genes are close to each other, but not lrp6 and lrp6.1. However, it
seems that if there is enough data lrp6 and lrp6.1 will end up close to each other. Some further
disadvantages have also been addressed:
• The dependency of each variable on its parents is a linear combination of the non-linear
functions of the parents values, and tanh is used as a nonlinear function. However, the
tanh() function is not necessarily the best function, even if it has shown a perfect fit with
the current models. log2 function, for example, could outperform it for a non-linear trans-
formation in another dataset.
• In setting the parameters on the scoring function (5.2), there are two sensitive parame-
ters, v and σ2 which are sample size and variance. These parameters greatly influence
what is learned, actually changing the structure of the Bayesian network, but there is no
optimal choice for setting such parameters. For example, the parameters are set to fixed
values in the tool σ = 1.0 and v = 3.0, in order to have a large variance (Ferrazzi et al.
2007). However, there is no guarantee that this is the optimal choice for these two param-
eters. (Silander et al. 2007) shows a similar scoring function ”BDeu marginal likelihood
score”, which has a single parameter, the equivalent sample size. It shows that the resultant
Bayesian networks are highly sensitive to the chosen parameter value. Another example
is the scoring function ”BGe score function” described in (Geiger & Heckerman 1994b),
which requires two parameters to be set, the sample size parameter and the prior network
parameter. It is used with different settings by (Friedman 2004).
• The maximum number of parents that each child is allowed is set to 5. Although, genetic
regulation networks are sparse, since for a given gene it is assumed that no more than a few
dozen genes directly affect its transcription (Friedman et al. 2000), we cannot find exactly
how many there are. Moreover, by setting the maximum number of parents randomly, we
might miss important parents.
• The version of the K2 algorithm used in this tool is implemented on the basis of a full or-
der assumed between the variables in the dataset. However, we know that we have partial
order in the dataset. The prior knowledge that we used from the KEGG pathways database
helps to order genes as one possible full order, as used in the previous tool, but some
genes will have parents even if the prior knowledge does not support this. For example
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the resultant graph in Figure 5.7 is based on the following order: PROC—WNT—DKK—
FRP—Frizzled—LRP5.6. Therefore, the graph has some irrelative relationships to the prior
knowledge, for exampleWNT10B → DKK1 which not exist in KEGG database. More-
over, each component or family of genes, for example the WNT family, also has several
genes that appear in the dataset, but their order remains unknown and using an arbitrary
order will result in some of them being missed. For example, the WNT family has a lot of
genes; if the order is ”wnt3, wnt5a, wnt6”, for example, we cannot check whether the data
supports ”wnt6→ wnt5a”.
5.4 The WinMine Toolkit
The WinMine toolkit is a set of tools created by Microsoft (Chickering 2002), which make it
possible to build statistical models from data. The main reason for using this tool is to make use
of partial ordering. In the previous tool, the dataset was assumed to have full ordering and there
was no choice to invoke a partial order, based on the ordering between components. One of the
features of the WinMine tool is that the variables in the dataset can be partially ordered. Figure
5.8 shows the method used to give a partial order to the tool.
Figure 5.8: Partial order screen in the WinMine tool.
Since we did not have access to the algorithms and the scoring function implemented in this
tool, the best we can do is to show the results we obtained from using this tool. The tool was
given a continuous dataset and partial order, the result obtained is a graph without connections,
as shown in Figure 5.9.
The result shown in Figure 5.9 is not encouraging, possibly because of the small sample size.
However, since the tool does not have a reference, apart from (Chickering 2002), we are unable
to provide any further reasons.
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Figure 5.9: The resultant network without edges from the WinMine tool.
5.5 Deal tool for learning the Bayesian network
The Deal tool is an R package that has the ability to learn a Bayesian network from contin-
uous, discrete or mixed data. It includes several methods for analysing data using Bayesian
networks (Bøtcher & Dethlefsen 2009) and does not require any assumption about ordering be-
tween variables. However, it allows the implicit ordering of variables, as shown below.
The scoring function used in Deal is the calculation of the posterior probability using Bayes
theorem for each Bayesian network as in (5.3).
P (BN |D) = P (D|BN)P (BN)
P (D)
(5.3)
P (D) is a constant and does not depend on BN; therefore, it is not necessary to calculate it
when comparing two networks. P (BN) is the prior probability of a Bayesian Network. In Deal,
all Bayesian networks are equally likely, therefore:
P (D|BN) ∝ P (BN |D)
To compare two Bayesian networks, a Bayes factor is used:
BF =
P (BN |D)
P (BNnew|D)
The Bayes factor is used to find the network with the highest score function when two net-
works are scored by (5.3).
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A basic heuristic greedy search was implemented in Deal to search the search space. The
network with the highest posterior probability is always preferable.
Deal allows the implicit invocation of the order to the dataset before learning. It is possible
to tell the algorithm that there are variables in the dataset about which we do not have prior
knowledge or which are not allowed to interact. We can use matrixn∗2, which bans certain
directions. This means that, for example, if we attach the following matrix to the network:
1 4
2 5
3 6

then we are asking the algorithm to disallow: Gene1→ Gene4, Gene2→ Gene5, and Gene3→
Gene6. Therefore, the values in the matrix are the indices of the variables in the dataset. The
resultant network is shown in Figure 5.10.
Figure 5.10: Incomplete results from the Deal package
The results in Figure 5.10 are incomplete, because the learning cannot be completed. The
error message received was ”cannot allocate vector of size 20.2 mb”. This is a memory problem,
which is to be expected, as the greedy search in Deal allocated all possible networks that differed
even by added, removed, or reserved arrows. It then used the BF ratio to compare each one with
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every other one, based on the posterior probability.
5.6 Summary
In summary, although we tried several different tools, none of them gave a satisfactory result.
The problems we observed can be summarised as follows:
1. The discretisation (Weka tool) yields poor patterns between genes; or
2. the tool (BN-Wizard) assumes a full order between variables and we do not have this in
the dataset; and,
3. there is no interpretable answer from the tool at all and it could not access the implemented
algorithms (WinMine); and
4. the learning phase crashed before the final result, due to the implementation of the algo-
rithm (Deal) and the memory capacity.
Another common problem among all tools is that we have a small dataset. As each tool
required a substantial amount of time for analysing the results obtained from it, trying other tools
for learning a Bayesian network from the dataset is time-consuming, as we are limited in terms of
time. Therefore, in the next chapter we will show another direction for learning graphical models
in general, which will lead to the methods developed and used throughout all the refined KEGG
pathways.
CHAPTER 6
Learning linear Gaussian models
Chapter 5 looked at some of the problems with existing tools, such as loss of information from
discretisation and the lack of full ordering in the dataset in Table 5.1. This chapter will show
the detailed direction of a new setting to solve the problem of learning graphical models from
continuous datasets. In Section 6.1, the problem of learning from sparse datasets and the goal of
model selection methods are addressed. The assumption of multivariate normal distribution is ex-
plained in Section 6.2, which shows how this assumption is assessed for the cancer dataset(stem
cell samples) in Table 5.1, the starting point for learning linear Gaussian models. Therefore, the
work in this chapter is also based on the cancer samples of stem cells that is used in the previous
chapter(Table 5.1). Section 6.4 is mainly about different variable selection methods, used to learn
from normal linear regression. Section 6.5 presents more sophisticated methods which contribute
to learning from gene expression datasets in this thesis. In section 6.7, an intensive evaluation of
the developed methods is shown, including: learning from large and small subsets of parents for
each gene, when 13 samples are used to learn from; validating the methods we developed with a
bigger dataset; and showing the robustness of the developed methods using statistical tests. The
last section examines to what degree the prior knowledge that is used to order variables in the
dataset in Table 5.1 is captured when the prior knowledge is not used.
6.1 Introduction
The problem of learning from a large number of candidates and small samples has recently been
addressed in the field of biology, because of the importance of data collection technologies. One
example of this is Affymetrix microarray data analysis techniques, in which the number of genes
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(predictors) to be examined exceeds the number of samples (observations). For such problems
, linear Gaussian models are used intensively to address the problem of model selection and the
ultimate goal is to achieve:
• An accurate prediction: The prediction and the most powerful predictors can be im-
proved by using methods that trade-off between bias and variance.
• An interpretable model: providing which predictors are meaningful rather than using all
predictors.
• Stability: by choosing the most important predictors, a small change in the data will not
result in large changes in the subset of predictors (Hastie et al. 2009).
In this chapter, predictor, independent, regressor and parent are used interchangeably. Further-
more, gene and child are also used interchangeably for dependent variables.
Since we are dealing with continuous variables, one of the most popular continuous distributions
used in graphical model learning problems is the class of multivariate Gaussian distributions, in
which the relationships between variables are in linear form. Moreover, a multivariate Gaussian
distribution can be generalised to encode non-linear relationships (Koller & Friedman 2009). In
this chapter, we are going to focus on the linear form of Gaussian distribution and proceed to
learn the linear relationships between each gene and its potential parents.
6.2 Multivariate Normal Distribution
A multivariate Gaussian distribution is a generalisation of a Normal distribution (one variable).
A p-multivariate Normal distribution with mean µ and covariance matrix Σ is denoted by ∼
Np(µ,Σ). If a dataset has a multivariate Normal distribution, then we can model the relationship
between a response and one or more regressors in a linear form. It is also known (Geiger &
Heckerman 1994a) that a multivariate Gaussian distribution can be decomposed into a product
of conditional distributions:
P (X1, X2, X3, ...) = P (X1)P (X2|X1)P (X3|X1, X2), ... (6.1)
where the relationship between parents and children fits a linear regression model. Thus, for each
gene we seek a subset of parents that are good predictors assuming the linear model (6.2).
µi = βi0 +
p∑
j=1
βijxij (6.2)
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6.2.1 Linear regression
Linear regression analyses the relationship between two or more variables. It expresses the linear
relationship, for example, between two variables X and Y in linear equation:
Y = β0 + β1x (6.3)
Where Y is a response variable and x is a single regressor or predictor variable. β0 and β1 are
the coefficients, and their values determine how the line is drawn between Y and x. Using linear
regression allows us to find the dependency between two or more variables, where Y is the de-
pendent variable and xs are independent variables.
An important quantity in linear regression is least squares error, which is the difference between
the actual value Y and the estimated value Yˆ . Therefore, if we know the actual value of Y in
equation (6.3) in advance, using x and the associated coefficients to predict Y is denoted as Yˆ
and least squares error can be used to find the prediction error by subtracting Y from Yˆ and
squaring it. The square is used for two reasons, to ensure the difference is a positive value and to
make least square errors correspond to the maximum likelihood.
A quantity close to linear regression is the correlation coefficient (r) which is found by:
r =
n∑
i=1
(Yi − Y¯ )(Xi − X¯)√
n∑
i=1
(Xi − X¯)2
√
n∑
i=1
(Yi − Y¯ )2
The correlation coefficient is fundamental to linear regression analysis, in which it expresses the
strength of the linear relationship between two variables. Two variables are said to be correlated
if a change in one variable is associated with a change in the other variable. The strength of the
relationship between two variables can be expressed in correlations, as in Table 6.1.
Table 6.1: Meaning of correlation coefficients between two variables X, Y
r = +1.0 The relationship is Strong-positive As X goes up, Y always goes up
r = +0.5 The relationship is Weak-positive As X goes up, Y tends to usually go up
r = 0.0 no correlation X and Y are not correlated
r = -0.5 The relationship is Weak-negative As X goes up, Y tends to usually go down
r = -0.1 The relationship is Strong-negative As X goes up, Y always goes down
It is important to note that when r = 0.0 it only means that there is no linear relationship
between X and Y. Thus, there might be a non-linear relationship between X and Y, which cannot
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be captured by correlation coefficient r. However, given the data is drawn from multivariate
Normal distribution, when r = 0.0 between X and Y, it implies that X and Y are independent.
6.3 Assessing multivariate normal distribution for the first part
of the Wnt signaling pathway dataset
The first step towards the regression learning problem is to assess the assumption of multivariate
Normal distribution for the dataset used. In this section, we assess to what degree the dataset for
the first part of the Wnt signaling pathway in Table 5.1(Chapter 5,page 64)meets the assumption
of Normality.
6.3.1 Work related to the normality of the first part of the Wnt signaling
pathway dataset
The assumption of normality is used in different ways in the literature. Some researchers assume
the Normality of the data for the dataset (Geiger & Heckerman 1994a). Other papers show that
discretising the dataset is the best choice for dealing with the data, since a continuous dataset
will allow us to find only the relationships between any child and its parents that are close to
linear (Friedman 2004). However, (Ferrazzi et al. 2007) states that it is possible to map the child
to its parents in a non-linear relationship, by using non-linear functions. Other research mentions
that, due to the nature of gene expression profile experiments and the possibility of errors, the
log transformed datasets satisfy the multivariate Normal distribution assumption (Waddell et al.
2000; Wu et al. 2003). Another way of not violating the assumption is (Parrish et al. 2009) which
suggests using a family of normalising transformations, from which a transformation is selected
for each gene that satisfies the assumption. However, it does not necessarily follow that, if each
gene has been drawn from a Normal distribution, the genes together follow a multivariate Normal
distribution, as will be shown below.
6.3.2 Normality test on the first part of the Wnt signaling pathway dataset
After reviewing the literature, it was found that different researchers have different opinions. It
might be that each gene expression dataset yields different results when analysed, due to the nor-
malisation process and the systematic differences resulting from such experiments. Therefore,
we found it important to investigate the assumption of normality for the dataset set rather than,
for example, assuming normality, without testing it and then linking the results with what has
already been found in the literature.
A lot of statistical tests can be used to assess the assumption of Normality for a given dataset.
A commonly used test is the Shapiro-Wilk test, which tests whether a sample is drawn from a
Normal distribution (a null hypothesis). Another way of testing the Normality of each gene is
to use a normal probability plot, which compares the cumulative distribution of the data values
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W = 0.5349, p-value = 8.416e-08
Table 6.2: The Multivariate Shapiro-Wilk test.
for a variable with the cumulative distribution of a Normal distribution. To test the normality
of the dataset, we used the multivariate Shapiro-Wilk test. Despite the small sample size, the
result obtained was encouraging. All genes apart from one (SFRP5) experimentally passed the
test shown in Figure 6.1, and 6.2 .
However, when the multivariate Shapiro-Wilk test was performed on the dataset, it failed.
The result of the multivariate Shapiro-Wilk test is shown in Table 6.2.
6.3.3 Discussion
The result of the multivariate Shapiro-Wilk test indicated that the dataset was not drawn from
a multivariate normal distribution. However, if we look at the Normal and multivariate normal
analysis in Figure 6.1, 6.2 and Table 6.2, we can see that three results were obtained:
1. When each gene was assessed for Normality, only one of them, SFRP5, failed the test. We
therefore accept that each gene was drawn from a Normal distribution.
2. When we assessed the entire dataset, the test showed a small p-value. Therefore, the dataset
was not drawn from a multivariate Normal distribution.
3. By looking at the statistical value (W) of the multivariate Shapiro-Wilk test in Table 6.2, it
does not have a small value, but is > 0.5 and we know that the closer it is to one, the more
Normal is the dataset (Shapiro & Wilk 1965; Dudley 2010).
Based on the results above and the small samples we have (the most important factor when a
statistical test is used), it is acceptable to say that the assumption of normality has approximately
been assessed as positive even if the entire dataset did not pass the test. It should also be men-
tioned that, prior to the pre-processing steps at the beginning of this work, a lot of genes could not
be improved in terms of their normality, fortunately, the different pre-processing steps removed
them from the dataset. Moreover, it is widely accepted in the community to assume normality for
gene expression datasets, as long as the hope is to find useful results which will help biologists
to understand how complicated cellular systems work.
6.4 Variable Selection Methods for Learning a Graph
After accepting that the dataset was approximately drawn from a multivariate Normal distribu-
tion, the problem of learning a graph is essentially based on learning the best predictors of each
gene based on gene expression values. In this section, different methods will be examined on
finding the best co-expressed genes(predictors) for each gene(dependent/child) and then a final
method for learning a graphical model from a sparse gene expression dataset(13 samples) will be
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Figure 6.1: Shapiro-test and normal probability plot for the 13 cancer samples(stem cell) (1).
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Figure 6.2: Shapiro-test and normal probability plot for the 13 cancer samples(stem cell) (2).
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proposed. Research in this area states that there is no progress in subset selection in regression
as long as the estimation of regression coefficients is concerned (Hesterberg et al. 2008; Miller
2008). Therefore, we examine different methods for variable selection and parameter estimation
as well as examining the advantages and disadvantages of each method.
6.4.1 Learning a co-expression graph
As the problem of learning a graph is now based on a multivariate Normal distribution assump-
tion, we can represent the dependencies in a linear regression relationship. We can also think
about the correlation coefficients as a score function for subset selection(6.2.1) in linear regres-
sion. If a vector X is normally distributed ∼Np(µ,Σ), then any two variables x1, x2 in X that
are uncorrelated r(x1, x2) = 0.0,are independent x1 ⊥ x2.
Therefore, the correlation coefficient can be used here to determine a small subset of parents
that have the most co-expressed relationships with the child. If a parent has a high correlation
with a child, we conclude that this parent has a strong linear relationship and therefore is a good
predictor for the child. Thus, finding the best subset of parents will be controlled by a correlation
coefficient (Markowetz & Spang 2007) and parents with high correlations with the child will be
included in the model. The literature shows that, if the dataset has fewer than 30 samples, using
the correlation is not enough and it is important to find how significant the correlation is (Hair
et al. 1998). For that reason, we use a statistical test, with correlation coefficients as a score
function, to choose the best parents for each gene since we have only 13 samples . A t-test im-
plemented in the R package is used and the p-value is set to 0.05. The null hypothesis in the test
is that the correlation r(x1, x2) = 0.0 and therefore the alternative hypothesis r(x1, x2) 6= 0.0.
After the test was done, each child had a set of parents that are significantly high correlated with
it.
In learning a graph using correlation coefficients, we put some natural constraints on the
genes/gene families (components) in the dataset using the same prior knowledge used in Chap-
ter 5 from the first part of the Wnt signaling pathway in KEGG, shown in Figure 4.8 as follows:
1. The PORCN component indirectly affects the WNT component.
2. The Dkk component inhibits the LRP65/6 component.
3. The FRP component inhibits the WNT component.
4. The WNT component activates the Frizzled component.
5. The Frizzled component activates the LRP6/5 component.
Therefore, all possible subsets of parents for each gene in the search space are going to be
relatively small. For example, when searching for possible parents for WNT3, the parents that
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are allowed to be in the subsearch space for gene WNT3 come from the PORCN component and
the WNT component (the genes come from the same family of WNT3, since the target initially is
also to find how the genes in each component interact with each other). Thus, based on the prior
knowledge from the KEGG pathway, the genes that are highly correlated will be represented by a
directed arrow, if KEGG shows any relationship. However, if two genes are highly correlated but
KEGG does not show any prior knowledge for them , then the relationship will be represented
by an undirected arrow.
As we have emphasised in Section 1.3.2 that the work in this thesis is based on transcriptional in-
teractions but the relationships in KEGG mostly are based on protein-protein interaction. There-
fore, the resultant graph holds relationship between nodes that represent gene expression values
which can be an abstract level to understand how protein-protein interaction happen in the cell.
The network resulting from the experiment is shown in figure 6.3.
Figure 6.3: Coexpression Network using correlation coefficients and t-test.
6.4.1.1 Discussion
The network in Figure 6.3 shows the undirected and directed relationships between genes based
on gene expression values and the prior knowledge retrieved from KEGG. The score function
used here has restricted the child to having the best parents in the dataset, which is effective in
terms of reducing the variance, and minimizing the bias at the same time. However, doing so
might lead the learning to miss some of the parents. To illustrate this, consider the fzd8 node in
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Figure 6.3. Based on the pair-wise correlation, sfrp1, sfrp11 and wnt7a are the parents of fzd8
and the residual sum of squares (RSS) for this sub-model is 0.4080789. Suppose that we added
one more parent from the set of parents which were removed by the significant test, say wnt5a
and wnt5a.1. The error for the sub-model is going to be smaller. Thus, generally, the correlation
coefficient can find that X1 is a parent of X2, while X3 is not, but cannot find that X1 and X3
together might be parents of X2.
To illustrate the general concept here we take Exclusive-OR (XOR) logical table in 6.3 as an
example. In a XOR logical table, ’A’ values alone cannot determine the output values and also
’B’ values alone cannot determine the output values. The only way to get the right logical value
is to take A and B together as an input to get the correct output.
Table 6.3: Exclusive-OR logical table.
Input A Input B Output
0 0 0
0 1 1
1 0 1
1 1 0
Another explanation of the drawbacks encountered in co-expression network is that adding
parents to reduce RSS is not a good choice either, since the model might suffer from overfitting.
Therefore, learning a graph using only correlation coefficients is not enough to determine the
best subset of co-expressed parents for each gene.
6.4.2 Learning a graph based on the penalised goodness-of-fit
After we have addressed the potential problems arising from using RSS and correlation as a
measure of how well the model fits the data, the next step is to consider all possible parents
from KEGG, for the child and then choose the best subset among them, using different criteria.
This is done by constructing all the possible candidates in the search space exhaustively and then
using an additive score function that penalises the more complex models. In this work the score
functions that we use are a version of Akaike Information Criterion (AIC) (6.4) and Bayesian
information criteria (BIC) (6.5). AIC is given by:
AIC = n log(RSS/n) + 2p (6.4)
Where 2p discourages the overfitting (p = length(βi) 6= 0.0), p is the number of non-zero
coefficients. AIC tries to find the model that best explains the data, with a minimum of free
parameters. The best subset of parents for each gene returned by AIC has the smallest AIC.
Section 6.4 Variable Selection Methods for Learning a Graph 87
BIC is like AIC in that it is possible when estimating a model’s parameters using maximum
likelihood estimation to increase the likelihood by adding more parameters, which could lead to
overfitting. BIC resolves this problem by adding a penalty to the number of parameters in the
model and the penalty for the complexity of the model is stronger than AIC. BIC is given by :
BIC = n log(RSS/n) + p log(n) (6.5)
The best subset of parents is the one with the smallest BIC. BIC also tends to penalise com-
plex models more heavily, giving preference to simpler models in the search space (Hastie et al.
2009). The potential problem, when no prior knowledge is used in the search space to find a
reasonable model, is that the number of models in the search space is super-exponential in the
number of observations (genes) and the possible subsets of parents grows very quickly with the
number of possible parents. Therefore, prior knowledge from KEGG is an important factor to
reduce the complexity of the search space. Several search algorithms have been proposed and in
this study we will examine how AIC and BIC are introduced in stepwise regression, all subset
regression, ridge regression and lasso estimate search strategies, along with the advantages and
disadvantages of each search algorithm.
6.4.2.1 Adjusted R2 score function for subset selection
Adjusted R2 is a generalised version of coefficient of determination R2. It is given as follows :
Adj −R2 = 1− SSE/(n− p)
TSS/(n− 1) (6.6)
Where :
TSS = SSE + SSR (6.7)
and,
TSS: the total sum of squares=
∑n
i=1(yi − y)2.
SSE: the sum of squared errors=
∑n
i=1(yi − yˆi)2.
SSR: the sum of squares regression=
∑n
i=1(yˆi − y)2, where yi is the actual value , y is the mean,
and yˆi is the predicted value.
In case that the best subset of parents for a particular gene is ∅, the mean is used (y) , there-
fore yˆ = y in SSR.
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Thus : ∀yˆi = y
SSR =
n∑
i=1
(yˆi − y)2 = 0.0, → TSS = SSE
and, as a result
Adj −R2 = 1− 1 = 0
This means that Adjusted R2 ignores the fact that some genes without parents might have a
higher score than if some parents are included.
6.4.2.2 Stepwise regression
The first attempt for variable selection based on penalised goodness-of-fit is stepwise regression.
The search begins either by assuming that all parents are possible for a particular gene, backward
stepwise search, and then removing each predictor in turn until the score function does not change
or becomes worse; or it assumes that the gene does not have any parents, and justifies this by
adding each predictor in turn, until the score function does not change or becomes worse Forward
stepwise search. The search can also add and remove predictors at the same time Forward-
backward stepwise search (Efroymson 1960). However, each stepwise search-score algorithm
returns a different model and all are a form of greedy search. Greedy search does not guarantee
to find the global optimal model, since the best predictor is chosen regardless of the future effect
and therefore the result of the search in stepwise search algorithms does not guarantee optimal
results. Greedy search generally lacks the concept of exploration before the exploitation, which
means that even if the search space is complete (the best optimal model exists) the greedy search
might not visit all the models and therefore misses the most consistent model. Therefore, in the
next section we use a complete search method ”all-subset selection” using a branch-and-bound
algorithm that guarantees to visit each candidate in the search space.
6.4.2.3 All-subset selection
All-subset selection is an expanded version of stepwise regression in which all models in the
search space can be visited; prior knowledge from KEGG will restrict the search space and make
the exploration manageable. To increase the effectiveness of the exhaustive search, a branch-and-
bound algorithm (Land & Doig 1960) that makes a complete search faster than a brute exhaustive
search is used.
In this search method, one step more has been taken before the search starts. Since the AIC
and BIC score functions rely heavily on RSS, for each family, the set of parents are examined
by RSS. If a set of parents in the regression model leads to RSS = 0.0, then the AIC/BIC score
is going to return = −∞ , which in turn gives unbeatable result. This is because the size of the
used dataset (13 samples, 25 observations) is likely to lead to overfitting. Therefore, each family
is examined before the search starts. If RSS = 0.0 the correlation coefficient (r) is used to drop
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parents with a small correlation with the child gene. The resulting models from search-score-AIC
and search-score-BIC are shown in Figures 6.4 and 6.5 respectively.
6.4.2.4 Discussion
The model chosen by BIC is sparser than the one by AIC, which is sometimes preferable, since
we would like to see the global picture of the co-expression between genes. This in turn helps to
read the graph more easily. However, there is no clear choice between AIC and BIC in general,
except for the following: given a search space that includes the true model, the probability that
BIC will get the correct model is 1.0 as N → ∞. However, as N → ∞, AIC tends to choose
more complex models. On the other hand, for finite samples, BIC often chooses models that are
simple, because of its penalty for complexity (Hastie et al. 2009).
The final result that we obtained looks at which genes from one component co-express or re-
act with which in another component. However, the results also show how genes in each gene
family react with each other. We observed that some genes in each gene family is dependent on
each other, where the undirected arrow is invoked, or one dependent on an another, where a di-
rected arrow is used. Therefore, the network contains cyclic families, which in turn leads to a set
of graphical models called dependency networks (Heckerman et al. 2000). The prior knowledge
that is used shows that the graph we have is a collection of directed and undirected relationships.
Therefore, another view that needs more investigation is that the graphs in Figures 6.4 and 6.5
have directed co-expressed relationships between blocks, undirected/directed or both between
genes inside each block, and acyclic relationships between blocks. This set of graphical models
is called Chain Graphs (Roverato & Rocca 2006; Aloraini et al. 2010).
However, the small dataset used in the experiments will not be a great help to investigate de-
pendency and chains graphs, because if we seek the best possible parents for a gene and we
include its family, a gene might have more than 13 parents from which to search the best combi-
nation. For example, there are 19 possible parents for FZD8, if the family of Frizzled is included
in the search, and 11 possible parents for FZD8 without its family. This is in cancer samples,
but in non-cancer samples the situation is worse since there are only 6 samples from which to
learn. Therefore, we paid attention to learning the directed relationships between families rather
than between families and within gene families. For example, we are keen to see which gene
from the WNT family co-expresses with which gene in the Frizzled family which might lead to
understand how protein-protein interaction between these two families happens. However, we
will not look at how Frizzled genes might work together, as this needs bigger datasets, and even
with the new settings, there are still some problems.
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Figure 6.4: The resultant graph from the search-score (AIC) method in normal linear regression.
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Figure 6.5: The resultant graph from the search-score (BIC) method in normal linear regression.
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A substantial problem in all-subset selection used in this study is that it focuses on variable
selection but not on the coefficients. The current approach is concerned about variable selection
and only estimates the coefficients using least squares/Maximum Likelihood after the predictors
have been determined. The advantage of using more continuous methods to estimate the best
predictors, along with the coefficients, is that they will result in fewer predictors for each gene.
It will also lead to the stability of the model in which a small change in the data will not result in
large changes in the subset of predictors. In the following sections, we will introduce shrinkage
methods that take extra care with parameter estimation, and proceed to show how the learning is
improved in two ways:
• When the resultant graphs are evaluated before and after the shrinkage methods are used.
• When the parents from the same gene family are invoked to learn the best subset of parents
for each gene and when only the predictors from other families are used.
6.5 Shrinkage Methods for Learning a Graph
Variable selection by stepwise regression considers either adding or removing predictors from
the regression model and this is beneficial, since the resultant model is usually interpretable. The
result from such a greedy search is usually unstable, as any small change in the data might cause
one variable to be chosen instead of another (Hesterberg et al. 2008). All subset regression on
the other hand, avoids this problem, because it considers each model in the search space and
returns the best model found. However, all-subset regression only takes care to choose the best
predictors, after that, it estimates the coefficients using the standard least squares. Shrinkage
methods are more continuous, and overcome the problem of exhibiting a high variance and the
increase of prediction errors when a discrete approach is used.
6.5.1 Ridge regression
Ridge regression is a shrinkage method that takes extra care in adding parents or predictors and
estimating the coefficients in a more robust way (Tikhonov & Arsenin 1977). Ridge regression
shrinks the regression coefficients by imposing a penalty on their size. Therefore, the ridge
coefficients minimise a penalised residual sum of squares.
βˆridge = argmin
β
{
N∑
i=1
(yi − β0 −
p∑
j=1
xijβj)2 + λ
p∑
i=1
β2j
}
Where λ ≥ 0 is a complexity parameter that controls the amount of shrinkage. If λ = 1.0, then
no parents are added. In contrast, if λ = 0.0 ridge regression returns an ordinary least squares.
No penalty is applied to the intercept (β0) and β0 equals y =
∑N
1 yi/n and also xij is centred
reparametrization. An equivalent way to write the ridge problem is:
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βˆridge = argmin
β
N∑
i=1
(yi − β0 −
p∑
j=1
xijβj)2, subject to
p∑
j=1
β2j ≤ s
If s = 0.0, no parents are added. In contrast, if s = 1.0 ridge regression returns an ordinary least
squares, where s is a shrinkage factor that controls the size of the βs in the regression equation.
Although Ridge regression carries out the variable selection and least estimate coefficients in
a continuous way, simultaneously, often the resultant model includes all possible predictors that
are allowed, but typically with smaller coefficients than they would have under ordinary least
squares (Hastie et al. 2009). This is because the imposed penalty (
∑p
i=1 β
2
j ) will shrink coeffi-
cients towards zero, but not exactly zero. Therefore, no variable is ever excluded from the model
(except when some coefficients cross zero for smaller values of λ).
6.5.2 Lasso
Lasso is a shrinkage method in which many coefficients are ‘shrunk’ to zero. This is because
the penalty for large coefficients in lasso is very severe, being the sum of the absolute values of
the regression coefficients
∑p
j=1 |βj | (in contrast to ridge regression βˆridge where the penalty
is less strict
∑p
j=1 β
2
j ). The lasso estimate βˆ
lasso for the regression coefficients for a particular
complexity parameter λ is:
βˆlasso = argmin
β
{
N∑
i=1
(yi − β0 −
p∑
j=1
xijβj)2 + λ
p∑
i=1
|βj |
}
(6.8)
or equivalently, (where s is determined by λ):
βˆlasso = argmin
β
N∑
i=1
(yi − β0 −
p∑
j=1
xijβj)2, subject to
p∑
j=1
|βj | ≤ s (6.9)
No penalty is applied to the intercept (β0) and β0 = y =
∑N
1 yi/n, and the xij are centred.
Figure 6.6 shows how the lasso estimate for each coefficient varies for candidate parents for gene
FZD7, as the complexity parameter varies from 0.0 to 1.0.
6.5.2.1 Related work
The lasso estimate has been used in a lot of research, as a technique for regularisation, variable
selection, or covariance selection for high-dimensional data, in which the number of predictor
variables is much larger than the number of samples(p  n). (Friedman et al. 2007) shows
the use of the glasso method, graphical lasso, in which an imposed penalty is introduced to the
inverse matrix
∑−1 to increase its sparseness. The solution of glasso shows that i ⊥ j given all
other variables if i, jth = 0.0 in
∑−1. (Peng et al. 2009) proposed a computationally efficient
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Figure 6.6: This Figure shows how the lasso estimate for each coefficient varies for candidate
parents for gene FZD7, as the complexity parameter varies from 0.0 to 1.0.
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approach for selecting non-zero partial correlations using L1-penalty under p n called Sparse
PArtial Correlation Estimation (space) where most variable pairs are conditionally independent .
The advantages of space over glasso is that in space prior knowledge is used in form of weighted
nodes according to their importance. Also, the complexity of space is min(O(np2, O(p)3) while
in glasso is O(p3) and therefore, the space is much faster than glasso. Two drawbacks are ob-
served from the previous studies when lasso estimate is used. Firstly, the same imposed penalty
for all nodes is used. However, each node might have different set of possible parents and there-
fore choosing the best subset of parents for each node using the same penalty is not an optimal
choice as the nodes with more possible subset of parents might need stronger penalty than the
nodes with few possible parents. Secondly, lasso estimate in the mentioned papers has been
found leads to undirected graphs and usually no natural background knowledge is used. Undi-
rected graphs are not always useful specially when the inference aims to discover the causality
between variables in a graph. As far as ascertainable, the only work used L1-regularization meth-
ods for a directed acyclic graph is by (Niculescu-Mizil & Murphy 2007) using big datasets.
In our work, a more constrained work is achieved using lasso estimate using small dataset. The
lasso estimate solution will be more constrained based on a natural prior knowledge from KEGG
database and feature ranking selection method and hence the resultant graph will be shown in the
context of directed relationships. Also, in addition to the traditional cross validation method to
choose the most probable regularizer (s), we show how AIC , and BIC score functions are used
to choose s when small dataset and natural prior knowledge are used. Moreover, we will show
that the lasso-AIC/BIC estimate solution corresponds to a global optimal solution even when a
small-scale dataset is used. Thus , it is guaranteed to choose the best subset of parents for each
gene found in the search space.
6.5.2.2 Using lasso and penalised goodness-of-fit for learning a graph
This section shows how AIC and BIC are used to evaluate the goodness-of-fit for each model
using the same data as used previously in the first part of the Wnt signaling pathway (stem cell ,
13 cancer samples). For each gene, the best subset of parents will be learnt and evaluated along
with the coefficients being estimated using lasso. Using lasso to estimate the coefficients will
cause some of the coefficients to be zero. Therefore, the number of predictors for each gene will
be relatively small. As it is always preferable to inject prior knowledge into the search space, to
minimise the complexity of the search, we put some natural constraints on the genes in the dataset
from KEGG, as before. In lasso, choosing the best model is subject to choosing the best value
for the tuning parameter(s in this case). The normal way is to use leave-one-out cross-validation
(LOOCV) to choose the best value of s. In this work, AIC and BIC score functions are also used
to choose the best value for s and then a comparison between the three methods will be shown.
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6.5.2.3 The best value of (s) using AIC and BIC
The best subset of parents for each gene is going to be chosen according to the most appropri-
ate value of the tuning parameter s (the regularisation parameter) which is chosen by the score
function: AIC or BIC. This is done by scoring all models that are returned by different values of
s. The model with the smallest AIC or BIC will be chosen as the best model and indirectly this
shows the best value of s. One more step was taken before the search started, since AIC and BIC
score functions rely heavily on the residual sum of squares errors (RSS), again if a set of parents
in the regression model leads to RSS = 0.0, then the AIC/BIC score is going to return = −∞ ,
which in turn gives a unbeatable score. This is because the size of the used dataset (13 samples,
25 observation) is likely to lead to overfitting. Therefore, each family is examined before the
search starts and the correlation coefficient (r) is used to drop parents with a small correlation
with the child gene if RSS = 0.0. Figures 6.7 and 6.8 show the best value of s determined by AIC
and BIC for the best subset of parents for genes WNT9A and WNT3,respectively.
6.5.2.4 The optimality of the lasso solution
The lasso solution is derived using a less greedy search (Hesterberg et al. 2008). Following
(Hesterberg et al. 2008), we have shown experimentally in this work that the lasso solution cor-
responds to a globally optimal solution, in terms of choosing the best subset of parents, although
the search-score algorithm that is used here, does not visit every model, every combination from
all possible subset of parents for each gene, in the search space. Figure 6.9(a) shows the lasso so-
lution when the AIC score function is used to score each subset of parents resulting from various
tuning parameter values (s). In Figure 6.9(a), AIC does not score every possible subset of parents
for each gene resulting from each single value of s (100 values between 0 and 1), but only those
subsets of parents that show up (their coefficients 6= 0.0) when a particular value of the parameter
makes change. For example, the change of parents subsets for WNT5B in lasso in Figure 6.9(a)
shows that there are only 15 models (subsets of parents) that have been scored (15 indices as in
the 3rd axis (top axis)). To show that the change of the subset of parents for each gene is only
for those that have been scored by AIC, we have plotted the path of each single value of s (100
values between 0 and 1) vs the change of parents in Figure 6.9(b) and we can see that the values
that do not change the subset of parents in Figure 6.9(b) are discarded by lasso-AIC in Fig 6.9(a).
This explains why, sometimes the setting of the problem helps to reduce the complexity of the
search, and instead of constructing all possible candidate parents for each value of s and then
using AIC or BIC to score each model (100 models) in the search space, we have only scored the
models returned from lasso, for example, 19 and 15 models in Figure 6.9(a).
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Figure 6.7: The best value of s determined by AIC for WNT9A.
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Figure 6.8: The best value of s determined by BIC for WNT3.
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Figure 6.9: The change of parameter values (a) vs the change of parents for each value of the
parameter (b).
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6.5.2.5 The best value of s using cross-validation
Another way of determining the best value of s is by using cross-validation, in which each value
of s is evaluated by leave-one-out cross validation. The mean of the prediction errors for each
value of s is used as a score for each value of s. Figure 6.10 shows the best value of the tuning
parameter(s) ≈ 0.121 which corresponds to the smallest error 0.17930 from the leave-one-out
LOOCV for gene FZD1. The bottom part of 6.10 shows the best parents for FZD1 after the best
value of s indicated by LOOCV.
After we have selected how the best value of s is chosen for each subset of parents for each
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Figure 6.10: The tuning parameter(s) is chosen by LOOCV(top graph) based on the prediction
accuracy for each value of s, and then the chosen s value used to find the best subset of parents
for FZD1(bottom graph).
gene using AIC, BIC and LOOCV, the results for the three methods, lasso-AIC, lasso-BIC and
lasso-LOOCV, are shown in Figures 6.11, 6.12 and 6.13. All the graphs contain directed cycles
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and therefore they can all be considered as dependency networks (Heckerman et al. 2000). When
we allow the genes within a component/gene family to be parents of a gene from the same com-
ponent/gene family , a cycle can arise. In Figure 6.13 we see that in the WNT family, WNT6 is a
good predictor for WNT5B and also WNT5B is a good predictor for WNT6. This is because no
prior knowledge is shown in KEGG between genes within the same family.
However, since we are learning from a small dataset, the risk of unreliable results is high. If
we are trying to find the best predictors for genes in the Frizzled family for example, we have to
consider families that have relationships with Frizzled (11 genes) and genes from within Frizzled
family (8 genes) as possible parents, which makes 19 parents in total.
In the next section, we will show new results, based on prior knowledge from KEGG that is
between gene families but not within families . We then show how the learning improved when
only the relationship between families was considered.
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Figure 6.11: The graph resultant from lasso-AIC.
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Figure 6.12: The graph resultant from lasso-BIC.
6.6 Learning a Graph Based on More Constraints on the Prior
Knowledge
In the previous sections, we have shown how different score functions in the setting of lasso
and normal regression were used to learn graphs based on natural prior knowledge gained from
KEGG pathways. For each gene, inside each gene family, all subsets of parents come from either
a gene family that has a biological effect (inhibition,...,etc.) or from within the same family of
the gene under consideration. As shown, the small dataset we have might cause overfitting if a
gene has a lot of possible parents, as 19 parents vs 13 samples in Frizzled for example, might
remove good parents just because RSS becomes ≈ 0.0. The previous setting of the prior knowl-
edge is important given a big dataset, as it reveals more unknown knowledge about the KEGG
pathways and the co-expression relationships between genes in order to get more information
about how the low-level protein-protein interaction occurs. However, we want to sacrifice im-
portant additional knowledge for the sake of getting more accurate results. In other words, we
want to minimise the bias and reduce the variance at the same time and hopefully improve the
overall prediction accuracy when well established score functions such as AIC and BIC are used
to learn subset of parents for each gene in the search space. Therefore, in the next learning step,
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Figure 6.13: The graph resultant from lasso-LOOCV.
we will put more constraints on the prior knowledge from KEGG and use only the relationships
between gene families but not within each gene family. This in turn, will reduce all the possible
subsets of parents for each gene (typically each gene will not have more than 12 possible par-
ents.). Figures 6.14 and 6.15 show part of the graphs after applying lasso-BIC and lasso-LOOCV
respectively when the new imposed constraints are used.
After the new setting for the prior knowledge from KEGG, all graphs (lasso-AIC, lasso-BIC
and lasso-LOOCV) are acyclic graphs and therefore a Bayesian network can fit here. In the next
section, we carry out intensive evaluation experiments to show how the learning improved after
the lasso estimate was used and also the reliability of the constrained prior knowledge.
6.7 Evaluation
One usual way of testing the performance of learned models is to use a separate data that has not
been used in training or generating the graphs. Another way is by doing physical experiments in
the lab using intervention methods (Friedman et al. 2000). However, since holding a spare data
for testing or doing physical experiments in the lab is expensive, a robust method called cross-
validation is used, in which the data is iteratively split to train and test (K-fold). The average
of the error1→N is used as a final error for the evaluation. In this work, leave-one-out cross-
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validation (LOOCV) is used, in which k = n. In the normal regression, one sample is reserved
each time and AIC and BIC score functions are used in the training, to choose the best subset
of parents for each gene. Then, the least estimates coefficients βs for the best subset of parents
which have been determined are used to predict on the reserved sample. As we have used leave-
one-out-cross-validation, we have tested each gene 13 times and each time, we used 12 samples
for training and we tested on the reserved one, recording the prediction error. Finally, the average
of error1→N is used as a final error for the prediction accuracy. The evaluation is done before
the constraints on the prior knowledge from KEGG are made and also after the constraints are
used. Figure 6.16 shows the prediction accuracy for AIC and BIC score functions in the two
different sets of prior knowledge.
The same procedure is used to evaluate the graphs from lasso-AIC, lasso-BIC and lasso-
LOOCV for the two sets of prior knowledge. In the lasso work, LOOCV is used as well as AIC
and BIC to choose the best parent each time a sample is reserved. In lasso-LOOCV there are two
layers of cross-validations. The first is to choose the value of s (internal LOOCV, Section 6.5.2.5)
and the second is when a subset of parents for a gene is evaluated (external LOOCV). Figure
6.17 shows the final prediction accuracy for lasso-AIC, lasso-BIC and lasso-LOOCV for the two
different sets of prior knowledge. After conducting all the experiments and by looking at the
different final errors from the different methods, we can see that using lasso with AIC, BIC and
LOOCV gives a better result than the normal regression before using the constraints on the prior
knowledge and also after introducing it. This explains how it is difficult to learn from a small
sample size, which is the usual case in gene expression profiles. One important explaination in
why lasso-score functions methods have succeeded, because using lasso makes estimating the
coefficients in a more robust way than the normal regression. Moreover, the results show that
using lasso-AIC, lasso-BIC and lasso-LOOCV with the constraints on the prior knowledge gives
a better result than when lasso is used without constraints (Figure 6.17).
6.8 A Comparison Experiment between Lasso-score Functions
and the Baseline Method
After showing that lasso with any score function, given constraints in the prior knowledge, works
better than the normal regression, and lasso without constraints, the next aim is to evaluate this
result using a different method not used in the experiments. One way to test how good the co-
expressed parents chosen by the proposed method (the lasso-score functions with constraints on
the prior knowledge), is to compare it to a baseline method. The baseline predictive accuracy
means that for each gene we reserve k = i and predict on the average of the training expression
levels (n − i) for this gene which will show if the subset of parents chosen for that gene by
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a b
Figure 6.16: The final prediction accuracy for AIC and BIC in the normal regression when genes
from the same family and other families are used in the subset of parents(a), and when only the
genes from other families are used in the subset of parents(b).
the proposed method in the previous section are meaningful(truly co-expressed parents) or if
the gene is better without parents (using mean predictive accuracy is better than any subset of
parents). The result in Figure 6.18 shows that the final prediction accuracy based on the average
of training gene expression levels obtained from the baseline method is better than any lasso
method proposed in Figure 6.17b. This initially means that the proposed method using lasso
estimate in the previous section performs worse than simply predicting on the average of the
training expression levels. This means that the gene is better without any parent and therefore
the data and the prior knowledge used are meaningless. Another explanation is that the data
used is really small (13 samples) and it is therefore hard to learn from. We have taken the latter
assumption and tried to investigate it more in the next section.
6.9 Learning Bayesian Networks Based on Feature Selection
and Lasso Estimate
In the previous section, we found that the baseline method suggested that each gene is better
without parents. In this section, we take more detailed steps to learn the most important parents
for each gene and then again compare the results with the baseline. This is because the small
dataset we have might need to be more constrained on the subset of parents chosen for each
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a b
Figure 6.17: The final prediction accuracy for AIC-lasso, BIC-lasso and LOOCV-lasso when
genes from the same family and other families are used in the subset of parents(a), and when
only the genes from other families are used in the subset of parents(b).
gene. Therefore, the subset of parents for each gene will be ranked according to the correlation
coefficients incrementally, from the highest to the lowest, called feature ranking (Guyon 2008).
Following this, leave-one-out cross validation (LOOCV) is used to test the prediction error each
time we remove a parent from the set of parents, as shown below. The advantage of using the
feature selection method here with lasso estimate , rather than the lasso estimate only, is that
when a subset of parents is examined using only the lasso estimate, the value of s that is deter-
mined by LOOCV is used to choose the best subset of parents from all possible parents one time.
However, when feature selection is used we make several choices based on the ranked possible
parents. Each time we remove a parent, we test how good the parent is and find the best s for this
subset of parents. Then, we remove the second best parent and we repeat the process again to see
how good it is and find the best s. We repeat the process until we test only the best parent alone
in the model. Therefore, there is a clear advantage for feature ranking over the lasso estimate
only, which undertakes this process in one go and using all the possible parents at the same time.
We will start with all parents and each time we remove the lowest parent we test by using LOOCV
and recording the prediction error. The test stops when it comes to test only the best parent for
this gene. Figure 6.19 shows how the prediction error changes for each gene when a parent is
removed from the subset of parents examined by LOOCV in lasso-AIC. Therefore, lasso-AIC,
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Figure 6.19: The prediction accuracy record for each subset of parents for each gene using feature
ranking for lasso-AIC.
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lasso-BIC and lasso-LOOCV are all run again, but this time with an embedded feature ranking.
Algorithm 1 shows how the methods work generally with the feature ranking method.
Algorithm 1 AIC-lasso, BIC-lasso and LOOCV-lasso with feature ranking
for i = 1 to length(Genes) do
Y = GENE[i]
PR = OrderParents(Y, corr(Parents))
for j = 1 to length(PR) do
SP = SearchSpaceFromlasso(Y, PR)
return BestParents = min[(AICLasso(SP ), BICLasso(SP ), LOOCV Lasso(SP ))]
return FinalError = LOOCV (BestParents(AIC), BestParents(BIC), BestParents(LOOCV ))
PR = PR[,−j]
end for
return BestParents(Y,min(FinalError))
end for
Thus, the experiment was run again, but this time the three methods return the subset of
parents for each gene that has the smallest error prediction resultant from a complex and an in-
tensive run using feature ranking. Following this, we compared the three modified methods to the
baseline and found that lasso-AIC, lasso-BIC and lasso-LOOCV work better than the baseline
method (Figure 6.20).
When we look at this procedure in detail, we can see that there are two layers of feature se-
lections. The first is ’feature ranking’ which is based on correlation coefficients. The second is
when a value of s is chosen by LOOCV which will return the best features based on the chosen
s, as shown in Figure 6.10 Section 6.5.2.5.
After lasso-AIC, lasso-BIC and lasso-LOOCV have beaten the baseline method, the next ob-
ject is to choose one of these three methods as a final product to learn a refined KEGG pathway.
The usual scenario is to test the proposed methods on a bigger dataset as a matter of verification.
Therefore, in the next section we will show how the methods work when a bigger dataset is used.
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Figure 6.20: The comparison between lasso-methods and the baseline after using feature ranking.
6.10 A Verified Evaluation Using a Bigger Prostate Cancer
Dataset
In this section, the methods developed in the previous section will be tested on a bigger dataset
not previously used in the study. The dataset consists of prostate cancer gene expression profiles
resulting from (Chandran et al. 2007). The cell files from this study are pre-processed using the
same techniques discussed in Chapter 5. The resultant gene expression datasets have 62 sam-
ples. We restricted the study to JAK-STAT pathway genes for a prior knowledge consideration.
Therefore, the final JAK-STAT gene expression profile used has 48 genes and 62 samples. The
maximum subset of parents for each gene does not exceed 14 genes. Figure 6.21 shows the final
error for each method when the big dataset is used. It can be seen that AIC-lasso works better
than any other methods including the baseline method. The baseline shows the worst prediction
error. For further assessment, it is important to test the significant difference between the chosen
method, AIC-lasso and the baseline method. Therefore, a K-fold-cross validated paired t test is
used as a significance test.
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Figure 6.21: The final prediction error for each method when a bigger dataset is used for com-
parison.
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6.10.1 K-fold-cross validated paired t test
This test is shown to be a powerful statistical test when two algorithms are compared in terms of
their prediction accuracy (Dietterich 1998). The evaluation in the previous section is based on the
error prediction from LOOCV. Therefore, when employing a t-test, these errors are the central
points of the test. To illustrate, the comparison between AIC-lasso and the baseline method will
be based on the prediction accuracy from each method. The difference between the prediction
accuracy in the two methods is pi = p1i − p2i . The result is a distribution of pi where i =
1 → k. Given that p1i and p2i are both approximately normally distributed and independent, their
difference pi is also normal (ALPAYDIN 2004). Therefore, the null hypothesis in the t-test is
that: µp = µp1 − µp2 = 0, and we are working towards rejecting this hypothesis (6.10)
t =
√
k(µp − 0)
S
(6.10)
Where,
S =
√√√√√ k∑
i=1
(pi − µ)2
K − 1 , µ =
k∑
i=1
pi
K
The result of t test = 3.596106, with degree of freedom = K-1= 62-1 = 61 give p-value< 0.05
from the t distribution table. Therefore, the accuracy of AIC-lasso is significantly different from
the baseline method. Moreover, the dataset we used shows a low variance between each gene
across samples. Figure 6.22 shows the variance for each gene across samples, for the dataset
we used for further evaluation in the previous section. It shows that the variance is low except
for ’SOCS3’. As mentioned above, the baseline method is about taking the mean of n − i and
predicting on i and therefore, given low variance we expect to see that the error resultant from the
baseline is small. However, AIC-lasso has shown a better result, even in this difficult situation,
and we regard this as another way of evaluating the result.
After showing that AIC-lasso has the best prediction accuracy on the bigger dataset, it is safe
to use this method in our study to learn all four extended KEGG pathways in the four different cell
types: cancer stem cells, cancer committed basal cells, benign stem cells and benign committed
basal cells. There are 13 samples in the cancer population and 6 samples in the non-cancer
population.
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Figure 6.22: The variability of gene expression values cross samples in JAK-STAT dataset.
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6.11 The Refined KEGG Pathways Using AIC-lasso with Fea-
ture Ranking
This section will show all the graphs learnt using the method developed above, AIC-lasso with an
embedded feature ranking, for the first block of the Wnt signalling pathway, for the four differ-
ent datasets (SC-cancer,SC-non-cancer,CB-cancer,and CB-non-cancer), the full graphs for the
whole datasets of the four prostate cancer pathways, and the full graphs for the colon cancer
datasets we experimented with. To ensure good interpretation and visualisation we used different
methods as follows:
For some graphs : each family of genes are encapsulated in a rectangle. The thickness of a line
means the amount of the directed co-expression relationship each gene has in other genes. The
sign illustrates the direction of the co-expression relationship. Thus, if it is ’+’ the interpretation
is:
• When the parent’s expression level increases, the child’s expression level is increased.
• When the parent’s expression level decreases, the child’s expression level is decreased.
If the sign is ’-’, the interpretation is :
• When the parent’s expression level increases, the child’s expression level is decreased.
• When the parent’s expression level decreases, the child’s expression level is increased.
6.11.1 The refined KEGG pathways for the first block of WNT KEGG
pathway using AIC-lasso with feature ranking
This section shows the resultant graphs for the first block of the Wnt signaling pathway. As we
have explained in the motivation of this work, all the graphs are an extended picture of how the
co-expression relationships occur between gene families represented in KEGG which have been
unknown previously. Understanding the co-expression relationships between genes in KEGG
will lead to understand how different protein-protein activation/inactivation happens on the very
low level of interaction in KEGG pathways , such as Wnt signalling pathway. mRNA-mRNA
interaction between genes can be a strong evidence to undertand how the protein-protein inter-
action happens in KEGG pathways, given that the proteins that function in the same pathway
are almost co-expressed (Webb & Westhead 2009). Figure 6.23 shows the first block of the Wnt
signalling pathway for stem-cancer samples and Figure 6.25 shows the first block of the Wnt
signaling pathway for committed basal-cancer samples. Figure 6.24 shows the first block of the
Wnt signalling pathway for stem-non-cancer samples and Figure 6.26 shows the first block of
the Wnt signaling pathway for committed basal-non-cancer samples.
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Figure 6.23: The refined 1st block of the Wnt signaling pathway for SC cancer samples.
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Figure 6.24: The refined 1st block of the Wnt signaling pathway for SC non-cancer samples.
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Figure 6.25: The refined 1st block of the Wnt signaling pathway for CB cancer samples.
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Figure 6.26: The refined 1st block of the Wnt signaling pathway for CB non-cancer samples.
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For more evaluation, we have done a comparison between the resultant co-expressed graphs
for cancer and non cancer samples and we show here the most important differences between the
behaviour of genes in cancer and non cancer samples. We have compared the stem cell cancer
graph in Figure 6.23 with the stem cell non-cancer graph in Figure 6.24 as follows:
• PORCN has more connections with the WNT family in SC-cancer than SC non-cancer.
• WNT5B in the WNT family has a higher directed relationship with FZD2 in SC non-cancer
than in SC cancer.
• WNT3 in the WNT family has a higher directed relationship with the genes in the Frizzled
family in SC cancer than in SC non-cancer.
• WNT7A has a high directed relationship with FZD8 in non-cancer SC, but a low directed
relationship with FZD8 in SC cancer.
• WNT9A has a high directed relationship with Frizzled genes in SC cancer, but a low di-
rected relationship in SC non-cancer.
• SFRP5 in the FRP family has a high influence on WNT7A in SC cancer. However, no
influence is detected in SC non-cancer.
Also, we report here the most important differences between gene connectivity in commit-
ted basal cell graphs, cancer and non-cancer samples, that are shown in Figures 6.25 and 6.26,
respectively, as follows :
• PORCN has the same amount of effect on WNT5B in cancer and non-cancer CB.
• DKK1 in the DKK family has a directed co-expression relationship with LRP6 in CB non-
cancer. However, no co-expression relationship was detected in CB cancer.
• SFRP5 in the FRP family has many co-expression relationships with the WNT family in
CB cancer, but no sign of any relationship between SFRP5 and the WNT family in CB
non-cancer.
• WNT3 in the WNT family has a single high directed co-expression relationship with FZD6
in CB cancer and the same amount of relationship between WNT3 and FZD6 is found in
CB non-cancer.
• WNT4 in the WNT family has a few high directed co-expression relationships with the
Frizzled family in CB non-cancer, but only a single relationship with FZD6 in CB cancer.
• WNT11 in the WNT family has more than one high directed co-expression relationship
with the Frizzled family in CB non-cancer . However, WNT11 did not appear in the WNT
family in CB cancer, because this gene was unexpressed (WNT11 < 50) .
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6.11.2 Linking the results of graphs with what is known in the literature
The results we obtained from AIC-lasso with feature selection method for the first block of the
Wnt signaling pathway were verified using cross validation and a significance test. In addition to
this, we linked the results obtained here with what is known in the literature about the individual
interactions between each learned paired genes. We used three different resources as follows:
• Information Hyperlinked over Proteins(IHOP)(Hoffmann 2004): a network used to search
millions of PubMed publication abstracts, to find if any interaction was found for a given
gene with any other genes.
• Gene database: It has a section which provides the interaction between a given gene and
other genes reported in PubMed publications.
• BioGRID: an online interaction repository, with references to the associated publications.
After searching the resources, we could not find any associated interactions for the datasets we
have, stem cells and committed basal cells for prostate cancer and non-cancer. The resources
largely report interactions between the families of genes, in the context of prostate cancer, such
as the WNT-Frizzled families interaction, which we have a prior knowledge about from the
graphical representation of the KEGG pathways we used. Therefore, this emphasises that the
underlying connectivity between families of genes in the Wnt signaling pathway is still largely
uncovered (Wang et al. 2009).
However, we have reported the same gene interactions in different samples that will be sum-
marised here.
In (Tanaka et al. 2000), PORCN is reported to interact with WNT5B and WNT6 in human
retina normal cells. We found that PORCN indirectly affects WNT5B in SC cancer and non-
cancer samples (Figures 6.23 and 6.24). It also had indirect influence on WNT5B in committed
basal cancer and non-cancer samples in which the amount of influence of PORCN on WNT5B is
high (Figure 6.25 and 6.26). PORCN indirectly affects WNT6 in CB samples, but only in cancer
samples in which PORCN has a low influence on WNT6 (Figure 6.25). In (Kim et al. 2008), it
has been reported that in Hepatocellular Caric from liver cancer, that WNT3 activates FZD7. We
also saw that WNT activates FZD7 in stem cell cancer samples and non-cancer samples, in Fig-
ures 6.23 and 6.24. The amount of directed co-expression relationship that WNT3 has on FZD7
is high in cancer samples, but in a negative direction. Thus, when WNT3 is up-regulated, FZD7
is down-regulated and when WNT3 is down-regulated, FZD7 is up-regulated. In stem cell non-
cancer samples, WNT3 also has negative activation in FZD7, but with a low level. In (Saitoh &
Katoh 2002), it has been shown that up-regulation of WNT5B, in several types of human cancer
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expressing FZD5, might lead to more malignant phenotypes. We saw in stem cell cancer sam-
ples (Figure 6.23) that WNT5B has a negative sign activation on FZD5. However, in stem cell
non-cancer samples in Figure 6.24, we have found a positive influence of WNT5B on FZD5, in
which the up-regulation of WNT5B leads to an up-regulated FZD5 and vice versa. This connec-
tion is missed in cancer samples from committed basal cell, but exists in non-cancer samples in
a negative direction (Figure6.26). In (Matsumoto et al. 2008), it has been reported that WNT9A
binds to FZD4 and FZD7 during liver development. This finding is also detected in the normal
stem cell and committed basal cells in the prostate sample (Figure 6.24,6.26), but in a specific
direction. These graphs show that WNT9A activates FZD4 and FZD7 in a positive direction.
(Lyonsa et al. 2004) reports that in kidney cell lines, WNT4 is found be bound to FZD6. In our
committed basal cell non-cancer samples (Figure 6.26), we have observed in a directed manner
that WNT4 has a high influence on FZD6 in a positive direction. However, in cancer committed
basal samples in Figure 6.25, we observed that WNT4 has a high influence on FZD6 but in a
negative direction. (Lyonsa et al. 2004) also shows that a member of Frizzled-related proteins
(sFRPs), SFRP1, was found to regulate WNT4. In CB cancer samples in Figure 6.25, we found
that another member of sFRPs, SFRP5, regulates WNT4 with a highly positive influence, but in
prostate cancer samples. (Caricasole et al. 2003) identifies that an interaction between WNT7A
and FZD5 is reported in PC12 cell lines. The activation of WNT7A leads to the expression of
FZD5. The non-cancer samples of CB prostate in Figure 6.26 show this interaction. Moreover,
(Caricasole et al. 2003) shows the detection of LRP6-FZD5 interaction in rat cell lines and we
also detected this in stem cell non-cancer samples in Figure 6.24. Finally, (Semenov et al. 2001)
shows that DKK1 is highly-affinity ligand for LRP6 in a rat normal cell line. We also detected
a directed relationship between DKK1-LRP6 in a committed basal non-cancer sample in Fig-
ure 6.26, which could be related to the finding in rat normal cell lines.
We hope that such similarity in gene interactions in different cell lines can lead to more nar-
rowed experiments, that reveal unknown discoveries, given that similar gene behaviours exist in
different cell lines.
6.11.3 The full refined prostate cancer KEGG pathways using AIC-lasso
with feature ranking.
After we developed the AIC-lasso method with the feature ranking method that is embedded in
it for the sparse dataset, to refine the first block of the Wnt signaling pathway, we extended the
application of this method to include all pathways that we are interested in. One important thing
to be noted is that the results we obtained for all pathways are for the genes for which we had
gene expression values. As stated above, the motivation was based on the fact that many of the
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genes have been annotated in the four pathways: JAK-STAT signaling in Figure( 4.5, page 56),
Wnt signaling in Figure( 1.4, page 21), the cell-extracellular matrix interaction pathway in Fig-
ure( 4.6, page 57), and the focal adhesion signaling pathway in Figure( 4.7, page 58). Therefore,
there are some genes which are known to be in these KEGG pathways, but as we did not have
gene expression values for them, we cannot know how they interact with each other.
Therefore, this section will show the fully refined signaling pathways for the four signaling path-
ways mentioned previously that have datasets in Table 6.4 and the result is 16 refined signaling
pathways represent four signaling pathways from Stem cells(cancer , non-cancers samples), and
Commited basal cells(cancer, non-cancer samples). Due to resolution issues with A4 page size,
we show here the refined Wnt-signaling pathway for stem cells cancer samples in Figure 6.27.
The rest(15 graphs) are all included in the CD attached with the thesis.
Table 6.4: Each pathway and its dataset
Pathway Number of Samples Number of Probes
Wnt signaling 451 probes
JAK-STAT 38 samples (19 SC,19 CB) 398 probes
Cell-extracellular matrix interaction 13 cancer,6 non-cancer 291 probes
Focal adhesion signaling 705 probes
6.12 Identifying the crucial causal relationships among genes
involved in colon cancer treatments using Illumina mi-
croarray
In Chapter( 4,Section 4.4.4), we obtained the normalised data for the four treated colon cancer
cell lines and for the control colon cell line. In this section, we investigated how the AIC-lasso
with the embedded feature selection can be used to show a more detailed picture of how the
treatments have altered the behaviour of gene interactions. The work achieved here is based on
two known KEGG pathways that have been found enriched with many genes in all five cell lines:
the MAPK signaling pathway and the cell cycle signaling pathway. In this section we will give
the results of 5 − Fluorouracil + Leucovorin treatment in MAPK signaling pathway genes,
Figure( 6.28). Likewise the control colon samples interactions found also in MAPK singaling
pathway are shown in Figure 6.29.
Using the graphical representation for all treatments vs the control graph it will be possible to
spot the differences and the similarities between genes behaviours and hence more inside details
have been shown in these graphs. However,since this study has been done abroad , there might
be more biological meanings of the results but we could not be able to discuss it with biologists
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Figure 6.27: The refined Wnt signaling pathway (stem cell) cancer samples using AIC-lasso with
feature selection.
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Figure 6.28: The interaction between colon cancer genes found in MAPK signaling pathway
after Fluorouracil + Leucovorin treatment is applied.
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Figure 6.29: The interaction between colon control genes found in MAPK signaling pathway.
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due to lack of communications. So, we consider that the main reason here is to show that the
developed method worked in a smaller dataset(5 samples) than the ones we have used in my main
goal(13 samples in cancer and 6 samples in non-cancer). The rest of the graphs(8 graphs) for all
the treatments are all included in the CD attached with the thesis.
6.13 On learning without prior knowledge
In this section, the prior knowledge from KEGG will be evaluated on the basis of how infor-
mative it is. The idea is to use the dataset in Table 5.1 without injecting prior knowledge from
KEGG, to see if the true parents represented in KEGG can be found, when no prior knowledge is
used. Using lasso-methods or normal regression without KEGG information will basically lead
any method to get stuck in either −∞ values or overfitting issue, as explained in the previous
sections, since without KEGG each gene will have 25 possible parents. Therefore, another exist-
ing method implemented in the R-package, graphical lasso (glasso), is used, to find out whether
the prior knowledge from KEGG can be found when only the dataset is used, without the KEGG
background knowledge. The glasso method works as follows: given the dataset has a multivari-
ate Normal distribution with mean µ and covariance matrix Σ ∼ Np(µ,Σ), an imposed penalty
is introduced to the inverse matrix
∑−1 to increase its sparseness. The glasso solution shows
that if ij = 0.0 in
∑−1, then i ⊥ j given all other variables (Friedman et al. 2007). The result of
this method is depicted in Figure 6.30 with different values of λ. The results show that there are
many incorrect dependences between genes, for example, when λ = 0.1 there is a dependency
between PORCN and SFR1.1, PORCN and FZD5.1, but KEGG does not have these dependen-
cies. Also, as λ increases, many dependences in KEGG are discarded by glasso. Therefore, this
is evidence that KEGG background knowledge is informative and needed in finding the optimal
subset of parents for each gene.
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Figure 6.30: The dependences found by glasso for different values of λ.
CHAPTER 7
Conclusion and Future work
This chapter summarises the thesis, including revisiting the motivation behind the work and
discussing the contribution of the thesis towards effective computational biology methods in
Section 7.2. Section 7.3 reviews the chapters involved in this thesis, and at the end of this chapter,
a discussion about the limitations of the thesis and possible future work is given in Section 7.4.
7.1 Introduction
Applying machine learning of graphical models has attracted many researchers, both in machine
learning and computational biology, to solve the problem of finding a more detailed picture of
how cellular systems work. With the existence of high throughput technologies, like microarrays,
it became possible to study the whole cellular system in one or two experiments. However,
almost immediately, biologists and geneticists realised that the genomic profiles resulting from
microarrays are far from manually manipulatable. Therefore, there is a great need for powerful
procedures, incorporating statistics and intelligent methods such as machine learning algorithms.
The machine learning community find the application of machine learning in real-world problems
will advance the ability to make knowledge-based systems available for computational biology
problems. It also opens research questions on how machine learning methods can be used with
genomic data. One of the most provoking research questions in machine learning at the present
is how to develop methods in sparse datasets. This kind of data is always produced as a result of
microarrays, where thousands of genes are measured in a few samples.
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7.2 Motivation Revisited
With the existence of microarray datasets, robust methods are needed to reveal new knowledge
that cannot be easily retrieved. The gene expression profiles resulting from microarrays are
not usually in a form which can be used by machine learning algorithms, because thousands of
genes, with only a few samples of each to learn from, is likely to lead to models that suffer from
overfitting. Learning graphical models from gene expression microarray data is one of the most
popular areas of interest among machine learning researchers. The advancement of low-level
interactions visualisation knowledge-based databases, such as KEGG pathways, has helped to
look at the problem of learning from gene expression profiles as a complementary step towards
more understanding of how gene interactions occur under a particular condition, such as cancer.
Therefore, the way we approached the problem in this thesis, was to make a contribution to what
is less complete in the current knowledge-based databases. The motivation was based on a study
by (Birnie et al. 2008) which uses cancer and non-cancer samples to highlight the differential
gene expressions between them in prostate samples. This led in turn to us focusing more on
where the genes that are involved in the study are annotated.
The genes are annotated in four different pathways: JAK-STAT signaling in (Figure 4.5, page 56),
Wnt signaling in (Figure 1.4, page 21), the cell-extracellular matrix interaction pathway in (Fig-
ure 4.6, page 57) and the focal adhesion signaling pathway in (Figure 4.7, page 58). However,
the research question that arose, is whether we can make use of machine learning to give a more
detailed picture about the gene interactions in these four KEGG pathways or not.
A class of machine learning algorithms, known as graphical models learning algorithms, have
been used throughout this thesis to contribute towards more understanding of cellular systems
and how each gene, in each pathway, interacts with those around it. One of the main motiva-
tions for using machine learning of graphical models in this research problem is the ability to
construct meaningful networks based on the injection of natural prior knowledge and the co-
expression relationships between genes , which is also helpful to smooth the complexity of ma-
chine learning search algorithms when applied to small datasets, which contain thousands of
variables (genes),Table (2.1,page 33). Prior knowledge from the KEGG pathways database al-
lows us to find which family of genes in each pathway co-expresses with which other families
for example , between WNT family and Frizzled family . However, the KEGG database does not
show which member of each family co-expresses with which member of the other family.
The main contribution of this thesis is to reveal what is unknown in KEGG pathways. We con-
centrated on discovering how the members of gene families work together in the four KEGG
pathways mentioned above. The prior knowledge that is obtained from KEGG allows the search
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space to be reduced, for example, when searching the possible subset of co-expressed genes for
each gene. We do not need to use all the variables in the dataset to find the best co-expressed
genes for a particular gene, only those that the KEGG database shows that the gene in question
interacts with. An example of this can be seen in the Frizzled family; the KEGG database will
retrieve that the WNT family interacts with the Frizzled family, which makes the search space for
each WNT member much less than the search space for WNT members without any constraints,
as the goal is to find out which gene of the WNT family co-experesses which gene in the Frizzled
family.
7.3 Summary of the Thesis Chapters
The chapters in the thesis have been organised to show the work from the starting point of the
research problem, through the progress of the work, until we end up with a method we developed,
which was used to learn from sparse datasets. The following sections give a brief summary of
each chapter and highlight the main findings when necessary.
7.3.1 Chapter One: Introduction
In this chapter, the state of the art of the research problem was discussed. This included the
transformation of 20th century genetics into 21st century genomic, through microarray technol-
ogy. We also highlighted the main issue with microarrays when we want to use statistical meth-
ods on the output. We discussed the curse of dimensionality for the gene expression datasets
that microarrays generate and how this kind of issue has given a huge consideration to statistical
machine learning methods and also made use of novel methods with vital genomic tools. We
then discussed the most useful machine learning techniques that are used in microarray analysis.
Finally, the motivation behind the work that has been achieved was detailed.
7.3.2 Chapter Two: Background
This chapter concerned machine learning in general with much attention to machine learning of
graphical models and related work in the context of microarray analysis. We discussed cluster-
ing algorithms, which are unsupervised learning algorithms, used to find the similarity between
gene expression profiles, if the finding aims for example to work out which genes show similar
patterns in different conditions, such as cancer and non-cancer. There was an introduction to Sup-
port Vector Machines (SVMs), that is one of the most successful supervised learning techniques,
either in microarray or other datasets. The robustness of SVMs comes from the projections that
the Kernel methods make on the data points in the space, so that a clearer separable hyperplane
can be used to classify the data points into two classes resulting in less prediction errors when a
new data point is used to test the classifier. In addition, we introduced graphical models which
are the main class of machine learning algorithms used in the thesis . Different sets of graphical
models were discussed, which were found in the literature to be the most commonly used, when a
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graphical representation of genes interaction is needed. The focus is on Bayesian networks for a
very biased reason, a directed co-expressed graph is needed to show how the interaction is influ-
enced between genes based on gene expression relationships . We then discussed how Bayesian
networks are learnt from data if there is no expert knowledge to construct the graphical represen-
tations between set of variables generally. We showed how the parameters are estimated after a
Bayesian network is constructed, and detailed a frequentist approach, Maximum Likelihood es-
timation (MLE). A Bayesian approach to estimating the parameters was also briefly mentioned.
Following that we highlighted the inference in Bayesian networks and a simple example was
used for demonstration. At the end of the chapter, we took a broad survey of the literature to
show how machine learning of graphical models is used to construct cellular systems.
7.3.3 Chapter Three: The Biology of Cancer
In this chapter, we tried to show the two most frequently diagnosed cancer types, breast cancer
and prostate cancer. We detailed how the two types of cancer occur, the ways breast cancer is
usually diagnosed and how they are both usually treated. We also detailed how the cell commu-
nication occurs between cells.
7.3.4 Chapter Four: Microarray Technology and Gene Expression Profiles
Data Analysis
This chapter goes through microarray technology and its practical use. At the beginning of the
chapter, different microarrays types are discussed and the Affymetrix microarray is discussed in
detail. The purpose of this chapter is to show how the intensity files, which are the results of
microarray experiments, are pre-processed in order to get readable and numerical datasets. We
then discussed the detailed steps of one of the most well known pre-processing algorithms, robust
multichip average (RMA), in normalising and pre-processing gene expression intensities. We
then showed how RMA is used practically together with other cleaning up steps to pre-process
the datasets that are used in this thesis. The RMA algorithm is used to pre-process prostate
samples from the Affymetrix microarray and colon samples from the Illumina microarray.
7.3.5 Chapter Five: Learning Refined Graphical Models for KEGG Path-
ways Using Existing Tools
This chapter details the first attempt to learn a graphical model from the first block of the Wnt
signaling pathway. Logically, we had to try existing tools to discover their advantages and dis-
advantages, as tools exist which are used to learn different sets of graphical models. Since we
emphasised previously that Bayesian networks are going to be used in this work, we tried sev-
eral different tools to learn Bayesian networks. Each tool has its advantages and disadvantages,
which were noted in this chapter. The common problem seen in all the tools we used was that no
robust way was found to invoke the prior knowledge gained from KEGG to simplify the search
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space. As we had a small dataset, prior knowledge is very important to reduce the search space
and hence less overfitting is encountered.
7.3.6 Chapter Six: Learning Linear Gaussian Models
This chapter shows the main contribution and the novel methods developed in this thesis. It shows
how the problem of learning can be considered as learning families of directed co-expressed
genes for each gene, and then joining them all together, to give a full graph for the dataset used
in learning.
At the beginning of this chapter, we set up the problem of learning as a linear Gaussian models
learning problem. This requires the assumption of multivariate Normal distribution. A multi-
variate Normal test, the Shapiro-Wilk, is conducted on the dataset to show to what degree the
dataset meets this assumption. After that, different attempts were shown on how a Gaussian
linear model is learned, starting with the simplest case, which is co-expression networks. We
detailed the drawbacks from using co-expression network to learn the full co-expressed relation-
ships between genes and then moved to show how penalised goodness-of-fit methods can be
used to learn more realistic co-expressed relationships between genes. We indicated that using
penalised goodness-of-fit methods can be improved using shrinkage methods. The lasso esti-
mate, which is used in this chapter, shows the advantage of using shrinkage methods over normal
regression methods and how the penalised scoring functions are used with the lasso estimate, to
obtain more robust results.
In this chapter, we also conducted intensive experiments to overcome the overfitting problem.
Consequently, this leads to make more constraints on the problem of learning a refined KEGG
pathway, by only considering interactions between families of genes rather than involving the
interaction between genes in each family. To strengthen the learning against overfitting, we also
included an embedded function, named feature ranking, which gives more robust results along
with the lasso estimate and the AIC scoring function, when overfitting is a concern. Moreover,
the method developed showed much better results than the baseline method, which considers that
each gene is best without parents. However, the results reveal that each gene has meaningful di-
rected co-expressed genes in the dataset, and also gave the optimal parents which could be found
in the sparse dataset.
Furthermore, we used a statistical test, the K-fold-cross validated paired t test to find out whether
the method developed, AIC-lasso with feature selection, works better than the baseline method
by chance or significantly. The result of the statistical test shows that AIC-lasso with feature
selection works significantly better than the baseline method used in the comparison. We also
had another way of comparing, this time with the prior knowledge used from KEGG. We tested
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whether the prior knowledge can be captured from only the dataset without using the KEGG
database or not. The result shows that using the KEGG database is important to add an extra
layer of meaning to the subset of co-expressed genes that are chosen by the developed method.
7.3.7 Chapter Seven: Conclusion and Future work
This chapter summarises the thesis and draws attention to future work and the limitations of the
datasets we have used.
7.4 Limitations and Future Work
In this work, we have had a chance to work with a difficult application, which always generates
sparse datasets. Microarray technology has given a new direction to treat many diseases such as
cancer, for example, by tracking the infected cellular systems of such diseases, then comparing
them to control cellular systems that are healthy and focusing on the differences for treatments.
However, in the existence of such small datasets, generated from microarrays, effective solutions
still need to be further considered, if machine learning algorithms are going to be used. The ef-
fectiveness of machine learning algorithms is solely based on the amount of data which is used.
To put it another way, to simulate any existing real-world problem, we need a big population to
work with, which unfortunately is not the case in microarray datasets. One of the critical eval-
uations we have encountered in this thesis is the limitation of the datasets we have had to work
with. In fact, the methods developed in this thesis were based on 13 samples.
The starting point for the motivation for this thesis was to refine the four KEGG pathways to
include the following:
• The study of all genes in each pathway; and
• learning how the interaction between genes inside each gene family occurs; and
• learning how the interaction between gene families occurs; and
• linking all four pathways together, as they have common genes.
However, because of the limited samples we had, the only point we looked at is how the
interaction between families occurs. We sacrificed a more detailed picture for the sake of the
global picture, and more accurate results. In future projects, we intend to do more work on
sparse datasets from microarrays and develop machine learning algorithms that can survive with
such data limitation. This research problem has very recently received huge attention among the
machine learning community. However, the way we will develop machine learning algorithms is
by using the natural prior knowledge that exists in the KEGG pathways. The goal then will be
to add an extra layer of information to what already exists in KEGG, and also to make sense of
graphical models in machine learning in real-world problems.
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The work we have done in this thesis reports a new direction in how the sensitivity of the tun-
ing parameter in lasso-estimate can be improved using feature selection methods such as feature
ranking when small datasets are used. So, in future work also we will look in more details how
the sensitivity of the tunning parameter in lasso-estimate can be improved when small datasets
are used in learning.
Another possible direction for future work is concerned with combining different datasets
from different microarrays experiments. Finding methods to combine different datasets from
different microarrays platforms is also being discussed intensively and this is because there are
many resources which exist for gene expression datasets and each suffers from small sample
sizes. To combine different gene expression datasets one has to be careful with the systematic
differences between the different datasets. The systematic differences include the temperature of
the lab when the genes are measured, the tools used to perform the experiments, such as the scan-
ner of the gene intensities that is used, and even the experience of the biologist who conducts the
experiment. All these issues have statistically prevented the datasets for one condition, but mea-
sured in different labs, from directly combining and being in one dataset. However, we believe
that since the multivariate Normal distribution assumption is being less restricted when dealing
with microarray datasets, combining different datasets from different resources to increase the
sample size will also receive less restriction statistically, as long as the hope is to find useful
information from such combinations. So that, in the future we will look at this interesting point
for more accurate machine learning methods to be applied in microarray datasets analysis.
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